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ANOVA analysis of variance
BBR blood-breath ratio
CNS central nervous system
DUI driving under the influence
ER emergency room
FT-IR Fourier transform infrared
(spectroscopy)
FVC forced vital capacity
IR infra red
LLOQ lower limit of quantification
LOD limit of detection
ppb parts per billion (by volume)
ppm parts per million (by volume)
SD standard deviation
SNR signal to noise ratio
VOC volatile organic compound
EtOH ethanol
MeOH methanol
1-propanol n-propanol
2-propanol isopropyl alcohol
MEK methyl ethyl ketone
MIBK methyl isobutyl ketone
MTBE methyl tert-butyl ether
N2 nitrogen
O2 oxygen
CO2 carbon dioxide
CO carbon monoxide
H2O water
N2O nitrous oxide
9Definitions
alcohol: any organic compound in which
a hydroxyl group (–OH) is bound to a
carbon atom, which in turn is bound to
other hydrogen and/or carbon atoms
solvent: liquid that dissolves a solid,
liquid, or gaseous solute, resulting in a
solution
matrix: environment from which a given
sample is taken (e.g., exhaled breath)
beamsplitter: a dichroic mirror in the
interferometer (Figure 2, page 25)
MCT detector: The MCT detector is
composed of a thin layer (10 to 20 µm) of
mercury, cadmium and telluride
(HgCdTe). Photons excite electrons into
the conduction band, thereby increasing
the conductivity of the material. The
change in conductivity is thus proportional
to the light intensity.
Peltier cooling: Peltier devices are small
solid-state devices that function as heat
pumps. A typical unit is a few millimetres
thick sandwich formed by two ceramic
plates with an array of small Bismuth
Telluride cubes in between. When a DC
current is applied, heat is moved from one
side of the device to the other—where it
must be removed with a heatsink. The
"cold" side is commonly used to cool an
electronic device.
mass-flow meter/controller: The operat-
ing principle of the mass flow meter is
thermodynamic. Resistance temperature
measuring elements are built in the sensor
tube. A precise amount of heat is directed
to the sensors (Aalborg), or between them
(Brooks). With no flow, the heat reaching
each temperature element is equal. With
increasing flow, the flow stream carries
heat away from the upstream element, and
an increasing amount towards the
downstream element. An increasing
temperature difference develops between
the two elements, and this difference is
proportional to the amount of gas flowing
or the mass flow rate. A bridge circuit
interprets the temperature difference and
an amplifier provides the output signal. In
a mass-flow controller, the signal from a
mass flow meter is further used to position
the precision solenoid control valve to
control the gas flow rate.
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Abstract
Technical or contaminated ethanol
products are sometimes ingested either
accidentally or on purpose. Typical
misused products are black-market liquor
and automotive products, e.g., windshield
washer fluids. In addition to less toxic
solvents, these liquids may contain the
deadly methanol.
Symptoms of even lethal solvent
poisoning are often non-specific at the
early stage. The present series of studies
was carried out to develop a method for
solvent intoxication breath diagnostics to
speed up the diagnosis procedure
conventionally based on blood tests.
Especially in the case of methanol
ingestion, the analysis method should be
sufficiently sensitive and accurate to
determine the presence of even small
amounts of methanol from the mixture of
ethanol and other less-toxic components.
In addition to the studies on the FT-IR
method, the Dräger 7110 evidential breath
analyzer was examined to determine its
ability to reveal a coexisting toxic solvent.
An industrial Fourier transform
infrared analyzer was modified for breath
testing. The sample cell fittings were
widened and the cell size reduced in order
to get an alveolar sample directly from a
single exhalation. The performance and
the feasibility of the Gasmet FT-IR
analyzer were tested in clinical settings
and in the laboratory. Actual human breath
screening studies were carried out with
healthy volunteers, inebriated homeless
men, emergency room patients and
methanol-intoxicated patients. A number
of the breath analysis results were
compared to blood test results in order to
approximate the blood-breath relationship.
In the laboratory experiments, the
analytical performance of the Gasmet FT-
IR analyzer and Dräger 7110 evidential
breath analyzer was evaluated by means of
artificial samples resembling exhaled
breath.
The investigations demonstrated that
a successful breath ethanol analysis by
Dräger 7110 evidential breath analyzer
could exclude any significant methanol
intoxication. In contrast, the device did not
detect very high levels of acetone, 1-
propanol and 2-propanol in simulated
breath. The Dräger 7110 evidential breath
ethanol analyzer was not equipped to
recognize the interfering component.
According to the studies the Gasmet
FT-IR analyzer was adequately sensitive,
selective and accurate for solvent
intoxication diagnostics. In addition to
diagnostics, the fast breath solvent analysis
proved feasible for controlling the ethanol
and methanol concentration during
haemodialysis treatment. Because of the
simplicity of the sampling and analysis
procedure, non-laboratory personnel, such
as police officers or social workers, could
also operate the analyzer for screening
purposes.
12
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1. Introduction
More than a thousand intoxication deaths
occur annually in Finland. Ethanol is the
most common single causative chemical: it
explains nearly half of the deaths (Vuori et
al. 2006). In the year 2003, there were 457
hospital care periods due to alcohol
poisoning, 9,777 due to alcohol intoxica-
tion (STAKES 2006). In 2004, 544 deaths
occurred due to ethanol poisoning—
methanol caused 26 and ethylene glycol 14
deaths. The proportion of methanol deaths
has remained high since the mid-1990’s,
mainly due to methanol-based windshield
washer fluids (Vuori et al. 2006).
Prompt treatment of methanol and
ethylene glycol intoxication is a
prerequisite for a good outcome. The
clinical signs and symptoms of solvent
intoxication are unspecific, at least at an
early stage, and medical history is often
missing or incomplete. Fast diagnostic
methods for non-laboratory personnel use
are needed not only in hospital emergency
rooms, but also in out-of-hospital settings.
Specific blood tests are in many
ways the golden standard where solvent
analysis is concerned. Gas chromatogra-
phy and enzymatic immunoassay are
commonly used methods for the
determination of serum alcohols. The turn-
around time of a gas chromatography
analysis or an enzymatic procedure is
approximately 1 h, when an on-site
laboratory is available to carry them out.
In many hospitals, specific methods for
methanol and ethylene glycol analyses are
not available and the samples must be sent
to an off-site laboratory, which markedly
extends the delay in diagnostics (Church et
al. 1997).
Faster (non-specific) laboratory tests,
such as the serum osmolal and anion gap
tests, are available to support the diagnosis
of a toxic alcohol poisoning until the blood
levels are available. However, a normal
osmolal gap does not exclude toxicity
from methanol or ethylene glycol (Glaser
1996), and increases in the osmolal gap
can also occur in patients with multiple
organ failure and other unmeasured
osmolal entities (Church et al. 1997).
Profound anion gap metabolic acidosis
suggests toxicity with methanol or
ethylene glycol (Church et al. 1997), but
anion gap acidosis becomes evident only
when the parent alcohol products are
metabolized to their toxic acidic
byproducts (Mycyk et al. 2003). There
have also been a few reports on analyzing
ethanol from saliva and sweat (Buono
1999, Smolle et al. 1999), but the method
has not been validated for other solvents.
Urine microscope analysis for crystals
caused by ethylene glycol poisoning
requires expertise and is by no means a
quantitative method.
The analysis of exhaled air provides
a non-invasive method for estimating the
concentrations of volatile components in
blood. Ethanol breath testing has been
used in intoxication diagnostics for
decades. However, rapid commercial
breath assays aimed particularly for
detecting toxic solvents are not available.
The present series of studies was
carried out to develop a new FT-IR
method for solvent intoxication breath
diagnostics. The new method should be
faster and easier than the old methods
without compromising the analytical
accuracy, sensitivity and selectivity.
Additionally, a commercially available
evidential breath ethanol analyzer was
examined to find out its capability to
reveal a coexisting toxic solvent.
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2. Review of the literature
2.1. Composition of normal
exhaled breath
The most abundant matrix components in
the human breath (Table 1) are nitrogen
(N2), oxygen (O2), water (H2O) and carbon
dioxide (CO2). Nearly 3,500 different
volatile organic compounds (VOC) were
detected by gas chromatography and mass
spectrometry in a study of breath samples
from fifty normal humans (Phillips et al.
1999). Sorbent traps were used in order to
concentrate these very-low concentration
compounds. Half of the VOCs were of
endogenous origin. An average breath
contained approximately 200 VOCs. Only
27 VOCs were detected in every breath
sample, nine of which were of endogenous
origin. The most abundant endogenous
VOCs found in more than half of the
breath samples were isoprene and acetone.
The analyzer in that study was not
configured to detect the small compounds
like ammonia, methane and carbon
monoxide. The absolute concentrations of
the components were not determined in
this study.
Interference from endogenous or
exogenous compounds may be an
important consideration when breath
analysis is adopted as a monitoring
technique for solvents. The above-
mentioned breath components are usually
present in low concentrations, when
compared to the level of solvents found in
breath following solvent intoxication.
However, it is essential to be aware of
possible interferences when low
concentrations of solvents are being
examined. In the case of acetone, carbon
monoxide or methane, quite high “normal”
breath concentrations may occur, and
interference is thus possible.
In the following, the most abundant
breath components are discussed from the
perspective of analyzing techniques based
on infrared spectroscopy.
2.1.1. Oxygen, nitrogen, water and
carbon dioxide
Exhaled breath contains approximately 5
vol% of carbon dioxide in its last
(alveolar) fraction. In addition, exhalation
is fully saturated with water vapour, which
means 5.2 vol% in the breath temperature
of 34 ºC (Hlastala et al. 1988, Lide 2000).
Water vapour may cause problems in
analysis due to its non-linear absorption in
the wide range of the infrared spectrum.
The strong infrared spectrum of water
overlaps the spectra of other breath
components (Figure 11, page 43). Sym-
metric diatomic molecules such as oxygen
and nitrogen are not detectable with the
infrared techniques (Hollas 1996).
2.1.2. Isoprene
Isoprene is a by-product of cholesterol
synthesis during the conversion of
mevalonate to mevanolate-5-pyrophos-
phate and isopentenyl pyrophosphate
(Sharkey 1996). Isoprene has been
reported by many authors to be the main
endogenous hydrocarbon in exhaled
human breath. In these studies, the mean
breath isoprene concentrations varied from
89 to 370 ppb in healthy volunteers
(Cailleux et al. 1989, Davies et al. 2001,
Hyspler et al. 2000, Karl et al. 2001).
Breath isoprene concentrations may fall
when cholesterol synthesis is suppressed,
for example, by treatment with simvastatin
(Karl et al. 2001, Sharkey 1996).
According to Cailleux and co-workers
(1993), the blood isoprene concentration is
approximately 3 µg/l in healthy adults.
2.1.3. Acetone
Acetone occurs as a metabolic component
in blood, urine and human breath. It can be
15
Table 1. Major components in normal end-exhaled breath.
Component Concentration Comments (references in brackets)
[vol%]
Oxygen < 21
Nitrogen ~ 70
Carbon dioxide 4–6
Water vapor < 5.2 in 34 ºC, 1 atm (Lide 2000)
[ppm] [µg/l]
Methane 0–120 0–76 mean ~ 20 ppm in producers
(Bjorneklett et al. 1982, Corazza et al. 1994,
Florin et al. 2000, Rumessen et al. 1994)
Carbon monoxide 1–3 1–3 in non-smokers
(Archbold et al. 1995, Irving et al. 1988, Middleton et
al. 2000, Uasuf et al. 1999, Yamaya et al. 1998,
Zayasu et al. 1997)
4–8 4–9 during airway inflammation
(Uasuf et al. 1999, Yamaya et al. 1998,
Zayasu et al. 1997)
14–24 16–27 mean in smokers
(Archbold et al. 1995, Irving et al. 1988, Middleton et
al. 2000, Yamaya et al. 1998, Zayasu et al. 1997)
Acetone 0.2–1.8 0.5–4 in healthy
(Jones 1987, Kundu et al. 1993, Smith D et al. 1999)
15–68 35–157 in adults after fasting 36 h
(Jones 1987)
14–168 32–287 in children on ketogenig diet
(Musa-Veloso et al. 2002)
148–868 343–2000 in dead diabetics (extrapolated from blood
concentrations) (Brinkmann et al. 1998)
Isoprene 0.1–0.4 0.3–1.1 mean in healthy
(Cailleux et al. 1989, Davies et al. 2001,
Hyspler et al. 2000, Karl et al. 2001)
Ammonia 0.2–1 0.14–0.7 in healthy
(Kearney et al. 2002, Smith D et al. 1999,
Spanel et al. 1998)
0.8–1.8 0.5–1.2 5 h after a liquid protein meal
(Spanel et al. 1998)
1 0.7 mean in chirrosis with hyperammonemia
(Shimamoto et al. 2000)
1.5–2 1–1.4 in uremic before dialysis
(Narasimhan et al. 2001)
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formed endogenously from fatty acid
oxidation. The endogenous acetone
concentration is low in healthy, normally
nourished people. Fasting and unbalanced
diabetes mellitus increase the endogenous
generation of acetone. Brinkman and co-
workers (1998) measured a significantly
higher mean endogenous blood acetone
concentration due to diabetic ketoacidosis.
Blood samples taken during the autopsy of
seven men had a mean concentration of
270 mg/l acetone. It corresponds with 478
ppm in breath, when 245 is used as the
blood-breath ratio (Table 2, page 20).
2.1.4. Ammonia
Ammonia derived from the catabolism of
proteins and amino acids is normally
present in breath in low concentrations.
Breath ammonia is increased in hepatic
disease (Shimamoto et al. 2000) and
uremic patients (Narasimhan et al. 2001).
It also increases during a Helicobacter
pylori urea breath test (Kearney et al.
2002). A breath ammonia concentration of
2.0 ppm has been reported in a uremic
patient before dialysis treatment
(Narasimhan et al. 2001). In blood,
ammonia is present mainly in ionized
form. Normally, the total ammonia blood
concentration is below 50 µmol/l .
2.1.5. Methane
Methanogenous bacteria are the principal
hydrogen-consuming bacteria in the large
intestine of methanogenic humans (“meth-
ane producers”). They use hydrogen to
produce methane and reduce flatulence
and bloating by the conversion of four
volumes of hydrogen gas to one volume of
methane gas (Florin et al. 2000).
In the international literature, the
prevalence of methane producers varies
from 10% to 54% of the population (Le
Marchand et al. 1993, McKay et al. 1985,
Peled et al. 1987). Possible factors
affecting excretion status are age, sex, diet,
bacterial flora, ethnic origin and intestinal
transit time (Florin et al. 2000). Patients
suffering from gastrointestinal diseases,
such as Crohn’s disease and ulcerative
colitis, have been found to produce less
methane than healthy controls (McKay et
al. 1985).
2.1.6. Carbon monoxide
Smoking, either passive or active, is the
main source of carbon monoxide (CO),
since inhaled tobacco smoke contains 4–5
vol% of CO (Kirkham et al. 1988).
Exhaled CO correlates well with the blood
carboxyhaemoglobin level (Guyatt et al.
1988, Jarvis et al. 1980). The wide range
of exhaled CO concentrations in smokers
is due to varying numbers of cigarettes
smoked per day and variation in the
interval between CO measurement and the
latest cigarette (Woodman et al. 1987).
Due to increased oxidative stress, exhaled
carbon monoxide concentrations are
slightly increased in inflammatory
respiratory diseases, as well. For example,
exacerbation of asthma has been shown to
raise the exhaled CO to 8.4 ppm and upper
respiratory tract infection to 3.8–5.6 ppm
(Yamaya et al. 1998, Zayasu et al. 1997).
2.2. Common intoxicating
solvents
2.2.1. Ethanol
Ethanol is the most common intoxicating
solvent. The small intestine extracts
roughly 80% of an oral ethanol dose; the
stomach absorbs the remainder. Since
ethanol is poorly absorbed from the
stomach, factors that delay gastric
emptying decrease the absorption. In
healthy adults, 80%–90% of the absorption
occurs within 30–60 minutes, but food
may delay complete absorption for 4–6
hours (Ellenhorn 1997, Jones et al. 2003).
Most of the ethanol is metabolized.
Conversion of ethanol to acetaldehyde by
alcohol dehydrogenase is the rate-limiting
step. The rate of metabolism varies to a
large extent, from 100 to 200 mg/kg/h
(Jones et al. 2003).
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Ethanol is a central nervous system
(CNS) depressant. Variations in ethanol
toxicity occur as a result of the concurrent
presence of hypoglycemia and drug
interactions. A blood concentration over
3.5 g/l is considered lethal (Winek et al.
2001). It corresponds with 830 ppm in
breath, when the blood-breath ratio of
2,300 is used (Table 2, page 20). Chronic
alcoholics can develop a marked tolerance
to ethanol and cope with blood levels
considered potentially fatal for non-
tolerant individuals (Ellenhorn 1997).
Treatment of acute ethanol intoxication is
mostly symptomatic.
2.2.2. Methanol
Methanol is a common industrial chemical
used for synthetic reactions or as a solvent.
For the general public, exposure may
occur through consumer products such as
paint removers, automotive fluids
(cleaners, windshield washer antifreezes)
and fuels as well as copying fluids.
Poisonings from methanol are relatively
infrequent, but can be lethal or very severe
in morbidity, possibly resulting in
permanent blindness or death (Davis et al.
2002, Jacobsen et al. 1997).
A methanol blood concentration over
6 mmol/l [20 mg/l] is considered toxic
(Winek et al. 2001). Nevertheless, there is
little correlation between blood levels of
methanol and the severity of the
poisoning, because it is the metabolites
that are toxic. In many cases, subjects
poisoned do not seek treatment until the
syndrome has developed into an advanced
stage. At that point, the blood methanol
level may be low (Jacobsen et al. 1997).
To date, the exhaled methanol
concentration in intoxicated patients has
not been reported in literature. Even
though the in vitro blood-air partition
coefficient is not equal to the in vivo
blood-breath ratio (see Chapter 2.3), it can
be used to roughly approximate the blood-
breath relationship. If a median in vitro
blood-air partition coefficient of 2,650
(Table 2, page 20) were used for blood-
breath conversion, the methanol blood
concentration of 6 mmol/l would
correspond to 60 ppm in breath.
The methanol toxicity includes an
initial CNS depression similar to but much
weaker than that produced by ethanol,
followed by a latent period of 10–30 h.
The latent period is generally shorter when
larger amounts are consumed and longer
when ethanol is also consumed. During the
latent period, methanol is metabolized by
alcohol dehydrogenase into toxic
compounds, formaldehyde and formic acid
(Ellenhorn 1997). After the asymptomatic
period, symptoms such as nausea,
vomiting, weakness, abdominal pain and
respiratory difficulties begin to appear. At
this stage, patients often report visual
defects ranging from blurring to total loss
of vision. The presence of deep metabolic
acidosis is common. In severe cases, the
result may even be coma or death (Davis
et al. 2002, Jacobsen et al. 1997).
Treatment of severe methanol
intoxication necessitates prompt
haemodialysis and metabolic inhibitors
(fomepizole or ethanol) in addition to
supportive treatment (Jacobsen et al. 1997,
Lushine et al. 2003).
2.2.3. Propanols
1- and 2-propanols are commonly used
industrial solvents. 2-propanol is often
added to ethanol-based windshield washer
fluids and cooker fuels. These products are
used by some alcoholics. 1- and 2-
propanols are roughly twice as toxic as
ethanol (Dreisbach et al. 1987). 2-
propanol is generally less toxic than
methanol or ethylene glycol, and the
toxicity is due to 2-propanol itself and to
acetone, its primary metabolite (Church et
al. 1997). 1-propanol may be slightly more
toxic than 2-propanol, but it seems to
induce many of the same biological effects
(Gosselin et al. 1984). The toxic blood
concentration for propanols is 0.4–0.8 g/l
(Maynard 2001). It would correspond with
160–400 ppm in breath, if median in vitro
blood-air partition coefficients (Table 2,
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page 20) were used for blood-breath
conversion.
The principal manifestation of acute
1- or 2-propanol poisoning is CNS depres-
sion. Chronic alcoholics may tolerate very
high levels of 2-propanol without
developing significant CNS depression
(Gosselin et al. 1984). The treatment of
isopropyl alcohol toxicity is primarily
symptomatic, with haemodialysis reserved
for refractory hypotension (Church et al.
1997, Dreisbach et al. 1987).
2.2.4. Ethylene glycol
Ethylene glycol is widely used in industry
and can be readily obtained by the
consumer, mostly as radiator antifreeze for
automobiles. Ethylene glycol is rapidly
absorbed orally and produces a CNS
depression roughly similar to that induced
by ethanol. Peak levels occur 1 to 4 hours
post ingestion. The liver oxidizes ethylene
glycol primarily into glycoaldehyde,
glycolic acid and finally to glyoxylic acid.
Depending on the cofactors thiamine and
pyridoxine, the metabolism of glyoxylic
acid follows several pathways which may
end in oxalic and formic acids. An
ethylene glycol blood concentration over
8–24 mmol/l [0.5–1.5 g/l] is considered
toxic (Anderson 2004, Winek et al. 2001).
The acidic metabolites are more toxic than
the parent compound (Ellenhorn 1997).
Due to its physicochemical properties, the
ethylene glycol concentration in breath is
very low, even in the case of severe
intoxication (see Chapter 2.3.1.).
Typically, 4–12 h elapse before
nausea, vomiting, hyperventilation,
elevated blood pressure, tachycardia,
muscular tetany and convulsions appear
after ingestion of ethylene glycol. More
specific signs are hypocalcaemia and a
severe metabolic acidosis. As the
syndrome develops, the outcome may be
cardiac failure, acute oliguric renal failure,
secondary CNS depression and coma
(Jacobsen et al. 1997). In addition to
supportive procedures, haemodialysis and
metabolic inhibitors are used to treat
severe ethylene glycol intoxications.
2.2.5. Acetone
Acetone is used as a chemical intermediate
and a solvent for paints, plastics and
adhesives. Exogenous acetone is rapidly
absorbed via respiratory and gastro-
intestinal tracts or through dermal contact.
Exhalation is the major route of
elimination for acetone (Baselt 2004).
Ingested 2-propanol is readily metabolized
into acetone. High concentrations of
acetone have been detected in alcoholics
who had drunk technical ethanol products
containing a few percent 2-propanol (Zuba
et al. 2002).
Acetone is less toxic than many other
industrial solvents. However, a high
acetone concentration can cause CNS
depression, cardiorespiratory failure and
death (Baselt 2004). According to
Maynard (2001), the threshold
concentration for toxicity is 200 mg/l in
blood. It would correspond with 354 ppm
in breath, if a median in vitro blood-air
partition coefficient 245 were used for
blood-breath conversion (Table 2, page
20).
2.2.6. Methyl ethyl ketone and methyl
isobutyl ketone
In addition to acetone, methyl ethyl ketone
(MEK) and methyl isobutyl ketone
(MIBK) are the ketone solvents with the
widest range of application in industry
(Kawai et al. 2003). They are also added
in low concentrations to ethanol-based
cooker fuels and windshield washer fluids.
The absorption of MEK and MIBK is
rapid via inhalation and ingestion, and
these compounds are moderate skin
penetrants, as well (Baselt 2004). Both
chemicals irritate mucous membranes and
have some CNS effect (Kawai et al. 2003).
Toxic plasma levels for MEK and MIBK
have not been defined. The occupational
threshold limits for under-15-min airborne
exposure are 300 ppm for MEK and 75
ppm for MIBK.
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2.2.7. Abused inhalants
Inhalant abuse is defined as deliberate
inhalation of a volatile substance to
achieve a change in mental state
(Kurtzman et al. 2001). A typical volatile
solvent abuser inhales the vapour directly
from a household product container or
places the product in a paper bag or on a
piece of cloth which is then placed over
the nose and mouth (Bowen et al. 1999).
Inhaled solvents enter the bloodstream
directly from the lungs and rapidly reach
the brain and other body organs. Blood
levels of most volatiles peak within a few
minutes of exposure and then decrease
rapidly as the substance is distributed to
the central nervous system and absorbed
by fat (Kurtzman et al. 2001). The
symptoms of an acute intoxication with
solvents are quite similar to those of
alcohol intoxication, but they are more
rapid in onset and briefer in duration
(Bryson 1989). An experienced user may
prolong the effects by concentrating the
drug inside a plastic bag and continuing to
sniff (Kurtzman et al. 2001).
In a recent study, the most
commonly used inhalants were glue, shoe
polish, gasoline and lighter fluid (Wu L-T
et al. 2004). Glues contain different
mixtures of easily volatile compounds. In
addition to toluene, these products may
contain xylenes, heptane, methyl ethyl
ketone, among other substances (Chao et
al. 1993, Midford et al. 1993). Toluene
blood concentrations among inhalant
abusers have been found to range from 0.1
to 92 mg/l (Chao et al. 1993, Park et al.
1998). Median concentrations were below
10 mg/l. This corresponds with 130 ppm in
breath, when a blood-breath ratio of 20.6
is used. There are no reports on breath
butane concentrations during or after
lighter gas abuse.
2.3. Pulmonary excretion of a
solvent
The results of breath testing are often
interpreted to correspond with blood
concentrations. Nevertheless, breath and
blood are two physiologically distinct
samples, and it may not be appropriate to
conclude that a breath sample provides
information which equates directly with a
peripheral venous blood sample (Wilson
1986). The term "blood-breath ratio"
(BBR) has been used to represent the ratio
of solvent (most often ethanol)
concentration in the blood to that in the
exhaled breath (Hlastala 1998) (Equation
10.1). For example, a blood-breath ratio of
2,100 is traditionally used to convert the
result of breath ethanol analysis into the
corresponding blood ethanol concentration
for medico-legal purposes (Jones et al.
2003). Instead of a single value of 2,100,
the ethanol blood-breath ratios derived
from simultaneous measurements of blood
and breath ethanol concentrations in
numerous human studies ranges from
2,160 to 2,475 (median 2,300) (Alobaidi et
al. 1976, Dubowski et al. 1979, Haffner et
al. 2003, Jones 1978, 1985, Jones et al.
1996a, 2003). In February 2003, the
Finnish legal breath-ethanol concentration
limits for DUI (driving under the
influence) were lowered to correspond
with the blood-breath ratio of 2,300
instead of 2,100: 0.22 mg/l (drunken
driving) and 0.53 mg/l (aggravated
drunken driving).
The blood-breath ratio of a volatile
compound is affected by several factors;
the most important of these are discussed
in the following.
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2.3.1. Blood-air partition coefficient
The partition coefficient (or partition ratio)
defines the distribution of a substance
(such as ethanol) between two media (such
as blood and air) at equilibrium (Equation
10.2). It is a physicochemical property of
the gas and the liquid at thermodynamic
equilibrium of the two phases involved at
the interface between the two materials
(Hlastala 1998). This equilibration obeys
Henry’s law in the case of low
concentrations (Equation 10.3). A partition
coefficient for a given compound is the
ratio of molar concentrations achieved
between the two compartments at
equilibrium. To describe the pulmonary
excretion, in vitro blood-air partition coef-
ficients have been determined for the most
common volatile compounds (Table 2).
A blood-air partition coefficient has
not been determined for ethylene glycol.
The Henry’s law coefficient for ethylene
glycol at 25 ºC is 20,000 times higher than
for ethanol or methanol. The correspond-
ing water–air partition coefficient at 34 ºC
is more than 10,000 times higher than that
for methanol, even if a quite high
temperature effect were assumed (Table
3). According to these data, the ethylene
glycol concentration in breath will be very
low, even in the case of severe
intoxication.
Table 2. Physical properties of solvents.
Component Molecularweight
Relative
density
Boiling
point
Vapour
pressure
at 20 ºC
Solubility
in water
at 20 ºC
Blood-air partition
coefficient at 37 ºC
(BBR in brackets)
g/mol g/l ºC Pa median range
Ethanol 46.1 790 79 5800 miscible 1566 1332–2516
(2300) (2160–2475)
Methanol 32.0 790 65 12300 miscible 2650 1626–2874
1-propanol 60.1 800 97 2000 miscible 1038 955–1120
2-propanol 60.1 790 83 4400 miscible 848 719–1426
Ethylene glycol 62.1 1100 198 7 miscible n.d. n.d.
Acetone 58.1 790 56 24000 miscible 245 196–330
MEK 72.1 810 80 10500 29 g/100ml 202 125–215
MIBK 100.2 800 117 2100 1.9 g/100ml 88 86–90
MTBE 88.2 740 55 27000 4.2 g/100ml 20 20
Diethyl ether 74.1 710 35 58600 6.9 ml/100ml 12.2 12.2
Ethyl acetate 88.1 900 77 10000 very good 98 77–120
Butane 58.1 600 -1 213700 * 6.1 µl/100 ml n.d. n.d.
Toluene 92.1 870 111 3800 none 15.2 15.6–14.7
(20.6) (18.2–23)
* at 21.1 ºC
BBR = in vivo blood-breath ratio at 34 ºC; MEK = methyl ethyl ketone; MIBK = methyl isobutyl ketone;
MTBE = methyl tert-butyl ether; n.d. = not defined
(Alobaidi et al. 1976, Dubowski et al. 1979, Fiserova-Bergerova et al. 1986, Foo et al. 1991, Gargas et al. 1989,
Garriott et al. 1981, Haffner et al. 2003, Harger et al. 1950, Imbriani et al. 1997, IPCS, Jones 1978, 1985, Jones et
al. 1990, 1996a, 2003, Kaneko et al. 1994, Pezzagno et al. 1983, Sato et al. 1979)
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2.3.2. Water solubility
Interaction in the conducting airway plays
a very significant role in soluble gas
exchange. For a gas of very high water
solubility, such as ethanol, practically all
of the exchange occurs in the airways.
During inspiration, the soluble gas
concentration in the incoming air becomes
gradually equilibrated with the
concentration in the airway mucosa,
according to the partition ratio. By
reaching the alveoli, additional soluble gas
is then taken up from the alveolar blood.
On exhalation, the air initially loses the
soluble gas to the alveolar end of the
airways, and progressively more loss to
the airway mucosa occurs along the entire
length of the airways. Exhaled alcohol or
other soluble gas leaving the mouth
therefore comes from the airway mucus
and underlying tissue rather than the
alveoli and blood in the pulmonary
circulation (Schrikker et al. 1989, Tsu et
al. 1991). The amount of soluble gas
reaching the mouth greatly depends on the
loss in the airways, which depends on the
breathing pattern and the air and airway
surface temperatures. This contributes to
the very large variation in the breath test
readings obtained from actual subjects
(Hlastala 1998). Due to the variation,
breath ethanol concentration has been
adopted as a basis for justification per se,
without attempts to convert it to blood
levels.
As the blood-air partition coefficient
of the exchanging gas decreases, the
importance of airway surface exchange
diminishes, and more of the gas exchange
occurs in the alveoli. For the normal
respiratory gases, O2 and CO2, only an
insignificant amount of exchange occurs
across the airways (Tsu et al. 1991).
2.3.3. Molecular size
Robertson and co-workers (1986)
compared the elimination of three inert
gases with similar partition coefficients
but with different molecular weights (26 to
184.5 g/mol). They discovered an order of
10% consistent impairment of exchange in
the higher molecular weight gases. This
Table 3. Henry’s law constants (Sander 1999).
literature calculated* Water-air
Component
at 25 ºC at 21 ºC partition ratio
[M/atm] [M/atm] [K]
Ethanol 1.90 E+02 2.57 E+02 6600 6197
Methanol 2.25 E+02 2.85 E+02 5200 6884
1-propanol 1.30 E+02 1.83 E+02 7500 4418
2-propanol 1.30 E+02 1.83 E+02 7500 4418
Ethylene glycol 4.00 E+06 n.d. n.d. n.d.
Acetone 3.00 E+01 3.70 E+01 4600 893
MEK 2.00 E+01 2.51 E+01 5000 606
MIBK 2.20 E+00 2.22 E+00 170 54
Butane 1.10 E-03 1.27 E-03 3100 0.03
Toluene 1.50 E-01 1.80 E-01 4000 4.3
* according to equation 10.3
MEK = methyl ethyl ketone; MIBK = methyl isobutyl ketone; n.d. = not defined
R
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was assumed to be due to an impaired
diffusion and a different distribution
between plasma and red cells.
2.3.4. Temperature
The normal human core temperature is in
the region of 37 ºC. The deep alveolar
temperature presumably equals the core
temperature. The temperature in the
airways decreases towards the mouth and
nose. The end-expiratory breath
temperature in normal circumstances is
approximately 34.5 ºC. According to Jones
(Jones 1982a), this temperature is reached
only when 90% of the forced vital capacity
(FVC) is exhaled. At 50% of the FVC, it
was 0.5 ºC lower. According to laboratory
and human studies, a rise in temperature
lowers and a decrease increases the blood-
air partition coefficient in the order of
6.5%–8.6% / 1 ºC (Fox et al. 1987, 1989,
Harger et al. 1950). Therefore, even mild
hypothermia or hyperthermia may
considerably distort the breath solvent
concentration and lead to an inaccuracy of
predicted blood solvent concentration.
2.3.5. Ventilation-perfusion ratio
In addition to the blood-gas partition ratio,
the fraction of the compound excreted to
breath is dependent on the corresponding
rate of alveolar blood flow and pulmonary
ventilation in different lung regions
(Equation 10.4). The ventilation is more
homogenous during light exercise than at
rest. Nevertheless, the effect of differences
in the pulmonary ventilation-perfusion
ratio is unlikely to affect the breath test
results by more than 3% for the majority
of industrial solvents that have blood-gas
partition coefficients greater than 10
(Wilson 1986).
2.3.6. Solvent distribution between
blood and other tissues
Ethanol is completely miscible with water
and distributes into the water compartment
of body fluids and tissue. During the
absorption of ethanol from the intestine,
the concentration of ethanol in the arterial
blood is higher than in the venous blood.
The magnitude of this arterio-venous
difference depends in part on the rate of
absorption of ethanol from the intestine:
rapid absorption exaggerates the difference
and slow absorption minimizes it. During
the post-absorptive state, the ethanol
concentration gradients between arterial
and venous blood are reversed. In a study
of twelve healthy men, the post-absorption
period began 6 to 77 min after a 30-minute
alcohol drinking period (Jones et al. 1989).
Due to the quite rapid absorption of
solvents, the breath testing generally takes
place in the post-absorptive phase (Jones
et al. 2003).
The breath ethanol concentration
reflects the arterial blood concentration
more closely than it does the venous blood
concentration. In the absorption phase, the
apparent (venous) blood-breath ratio is
therefore lower than in the post-absorption
phase. Hence if the 2,100 blood-breath
ratio were used for the breath-to-blood
conversion in the absorption phase, the
blood concentration would be over-
estimated (Jones et al. 1989). This effect
of distribution on the blood-breath ratio is
most probably similar for all highly water-
soluble components, but thus far no
studies have been conducted to verify it.
2.4. Breath sampling
The breath profile for exhaled gaseous
components is divided into three phases
(Figure 1) (Hlastala 1998). At the
beginning of the expiration, phase I
appears as a horizontal line representing
the airway dead space (approximately 150
ml) which contains little or no gases
derived from the blood circulation. The
hosing of the analyzer and the volume of
the measuring cell adds up the dead space.
The first phase is followed by a rapid rise
in concentration of volatile components
(phase II). The rise slows down to the
“alveolar plateau” (phase III) as the
23
alveolar air is reached (Hlastala 1998,
Lubkin et al. 1996).
Because of the airway exchange,
phase I is much shorter for water-soluble
solvents such as ethanol than it is for
components changing mainly in the alveoli
(CO2, N2). The concentration of volatile
components will still have an upward
gradient after reaching phase III, if a
subject continues to exhale at a constant
rate. In the case of CO2, the rise is slight
and mainly attributed to the continued
liberation of solvent gas from the alveoli.
The slope for readily water-soluble
solvents is somewhat steeper and caused
by a complex interactive process of heat
and gas exchange in the bronchial tree, as
well as the gas diffusion properties of the
peribronchial tissues. The rise in exhaled
solvent concentration will end only after
deceleration of the air flow at the end of
the exhalation. Consequently, the larger
the volume exhaled, the higher the
measured breath solvent concentration will
be. (Hlastala 1998)
A standardized and reproducible
breath sample is important for quantitative
breath analysis. If the breathing and
collection technique are not standardized,
the proportion of alveolar air and dead
space air will vary, leading to highly
variable data (Manolis 1983). A few
mathematical models have been developed
for describing the breath alcohol
exhalation profiles (George et al. 1993,
Lubkin et al. 1996, Tsu et al. 1991). These
models can provide a useful basis for
designing a breath solvent sampling
method. Usually, the aim is to obtain a
representative alveolar sample (Wilson
1986). A few topics of breath sampling are
presented in the following.
2.4.1. Breathing technique before
sampling
Jones (1982b) determined the influence of
the breathing technique on the temperature
and ethanol-content of the breath. With
30-second breath-holding before
expiration, he found the concentration of
ethanol to increase by 16% and the
temperature of breath by 0.6 °C.
Hyperventilating for 20 seconds immedi-
ately before the analysis of breath
decreased the concentrations of ethanol by
11% and produced a 1.0 °C fall in breath
temperature. After a slow (20 s)
exhalation, expired ethanol was increased
by 2%, with no changes in breath
temperature. In addition to temperature
changes, the duration of contact between
the breath and the mucous membranes
covering the respiratory tract was
concluded to represent the main reason for
the observed effects. Theoretically, these
findings are applicable to any very water-
soluble solvent.
2.4.2. Re-breathing
Breathing in and out of a reservoir for
several breaths (re-breathing), has been
used to obtain equilibrated alveolar gas
samples (Ohlsson et al. 1990). In the case
of water-soluble components such as
ethanol, the air within the lung and
reservoir system equilibrates after several
breaths, as the air passes back and forth
over the airways, warming the airways to
body temperature and equilibrating the
airways with the alveoli. After
equilibration, the reservoir air alcohol
Phase III
Phase I
Phase II
Exhaled volume
C
on
ce
nt
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n
Figure 1. Exhaled profile of a water-
soluble solvent (ethanol, solid line)
compared to a less soluble component
(CO2, dashed line) (Hlastala 1998).
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concentration should be equal to alveolar
air alcohol concentration. The isothermal
re-breathing could also counteract the
impact of altered pre-test breathing or
inspired air temperature (Ohlsson et al.
1990). Hypoxia limits the duration of the
re-breathing manoeuvre and thus prevents
a complete equilibration.
2.4.3. Methods for standardizing the
breath sample
The carbon dioxide concentration in
alveolar air is stable and more or less
constant in resting healthy subjects. A
minimum CO2 concentration could be
required in order to ensure the collection
of an appropriate alveolar breath sample.
In some studies, the concentration of
breath compounds from healthy subjects in
a fasting state has been normalized by
respiratory CO2 (i.e., the concentration in
breath is expressed as a fraction of the
total CO2 expired). It has been estimated
that normalization halves the standard
deviation for determining the concentra-
tion of breath compounds (Cheng et al.
1999). Nevertheless, it has to be kept in
mind that exhaled concentration/time
profiles are different for CO2 and water-
soluble solvents (Figure 1, page 23)
(George et al. 1993, Hlastala 1998, Lubkin
et al. 1996).
Because the temperature and the
total exhaled volume affect the water-
soluble solvent breath concentration, these
parameters can be used for sample
standardization. The demand of a
minimum volume (e.g. 1.5 l (OIML 1998))
in the breath test may not be sufficient by
itself, because the vital capacity varies
markedly between subjects. In order to get
a correct result, the expiration volume
should be more than 70% of the subject’s
vital capacity (Schoknecht et al. 1990). In
case of an expired volume remarkably
lower than 50% of the vital capacity, the
measured values can be more than 10%
below the expected values (Schoknecht et
al. 1990). If the breath analyzer has a very
fast response time for the analyte, the
plateau phase of the exhalation can be
verified during sampling. An appropriate
protocol to reducing variation is to obtain
at least duplicate breath samples (Lubkin
et al. 1996).
2.4.4. Control of volatile components in
the inspired air
Since a volatile compound in the breath
may have originated either from the body
or the inspired air, the collection method
should allow the determination of its
source. The amount of the compound
originating from the body can be
determined by calculating an alveolar
gradient (concentration in alveolar breath
minus concentration in room air). The
alveolar gradient is generally positive for
compounds produced by the body and
negative for environmental pollutants
(Phillips 1997).
2.4.5. Prevention of condensation
Breath is saturated with water. It should
not condense in the collecting apparatus,
since volatile compounds could be lost by
partitioning into the aqueous phase. All of
the tubing and reservoirs of the analyzing
system should be heated in order to
prevent any condensation (Phillips 1997).
2.5. Gas phase infrared
spectroscopy
Infrared (IR) spectroscopy is a chemical
analytical technique, which measures the
infrared intensity versus wave number
(wavelength) of light. Based upon the
wave number, infrared light can be
categorized as far infrared (4–400 cm-1),
mid-infrared (400–4,000 cm-1) and near
infrared (4,000–14,000 cm-1) (Hollas
1996). The Gamet FT-IR analyzer used in
the present studies operated in the mid-
infrared region.
Mid-infrared spectroscopy detects
the vibration characteristics of chemical
functional groups in a sample. When an
infrared light interacts with the matter,
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chemical bonds will stretch, contract and
bend. As a result, a chemical functional
group tends to adsorb infrared radiation in
a specific wave number range. For
example, the stretch of the C=O group
appears at approximately 1,700 cm-1 and
that of O–H at roughly 3,600 cm-1.
According to Beer’s law, the absorbance
of infrared radiation is directly
proportional to the concentration of the
sample and the path length (Equation
10.5). The total absorbance of the sample
is the sum of the absorbances of its
components. (Hollas 1996)
2.5.1. Fourier transform infrared
spectroscopy
There are alternative ways to record a
frequency domain spectrum. It can be
recorded by scanning through the
frequency range and recording the signal
at the detector. Alternatively, the time
domain spectrum can be recorded first and
then transformed to the frequency domain
spectrum. The process of proceeding from
the time domain spectrum to the frequency
domain spectrum is known as Fourier
transformation. (Hollas 1996)
There is an important advantage in
recording the time domain spectrum: all
the frequencies in the spectrum are
recorded all the time. This is known as the
multiplex or Fellgett advantage and results
in a comparable spectrum being obtained
in a much shorter time. An interferometer
(Figure 2) is used to modulate the infrared
spectrum before leading it through the
sample. The interferometer utilizes a
beamsplitter (B) to split the incoming
infrared beam (S) into two optical beams.
One beam reflects off of a flat mirror (M2)
fixed in place. The other beam reflects off
of a flat mirror (M1) which travels a very
short distance (typically a few millimetres)
away from the beamsplitter. The two
beams reflect off of their respective
mirrors and are recombined when they
meet at the beamsplitter. The re-combined
signal (D) results from the “interference”
of the beams with each other. The
resulting signal is called the interferogram,
which has every infrared frequency
“encoded” into it. When the interferogram
signal is transmitted through the sample,
the specific frequencies of energy are
absorbed by the sample. The uniquely
characteristic infrared signal is measured
by the detector and digitized. The digitized
signal is decoded by Fourier transforma-
tion to a spectrum, a plot of raw detector
response versus wave number. (Hollas
1996)
A spectrum obtained without a
sample (background spectrum) is induced
by the instrument and the environments. A
background spectrum must always be run
when analyzing samples by FT-IR. A
sample spectrum looks similar to the
background spectrum, except for the fact
that the sample peaks are superimposed
upon the instrumental and atmospheric
contributions to the spectrum. To eliminate
these contributions, the sample spectrum
must be normalized against the
background spectrum (Equation 1.1). The
final absorbance spectrum should be
devoid of all instrumental and
environmental contributions and only
present the features of the sample (Smith
BC 1995).
The FT-IR analyzer provides a
spectrum of a mixture of yet unidentified
gases with unknown partial pressures. A
computer with analysis software is
S
M1
D
M2B
Figure 2. Michelson interferometer (Hollas
1996).
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required to calculate the partial pressures
of the pure gases in the mixture (Ahonen
et al. 1996).
2.5.2. Advantages of low resolution
The resolution of the analyzer is
determined by the extent to which the
interferogram can be observed, and
depends on the maximum displacement of
the moving mirror. Slight mirror
movement leads to a low resolution
(Equation 10.7) (Hollas 1996). The
resolution in a low-resolution instrument is
defined as being more than 4 cm-1. The
most obvious advantages of low resolution
over high resolution are the simpler design
of the instrument, shorter measurement
time and higher signal-to-noise ratio
(Jaakkola et al. 1997).
For quantitative analysis, the most
important property of the spectrum is the
signal-to-noise ratio (SNR). The
uncertainty of the analysis results is
directly proportional to the baseline noise
in the spectrum and to the square root of
the spectral resolution. Thus, the SNR of
the spectrum has a stronger effect on the
uncertainty of the quantitative analysis
results than the instrumental resolution.
The resolution and SNR are inter-
dependent: increasing the resolution also
increases the noise, if the instrumental
conditions remain the same. Therefore, in
order to optimize the performance, it is
practical to maximize the SNR by
lowering the resolution (Jaakkola et al.
1997).
Non-linearity of a low-resolution
instrument can be an advantage in
increasing the dynamic range of
quantitative analysis, because in low
resolution, the absorbances measured at
high concentrations are lower than in high
resolution. This is a significant advantage
in the case of a low concentration
component required to be measured in the
presence of strongly absorbing
components with a high degree of spectral
overlap (Saarinen et al. 1991).
2.6. Existing solvent breath
tests
Portable and bench-top breath ethanol
devices have been available for many
years and are widely used for traffic law
enforcement. The earlier breath ethanol
analyzers based on single wavelength IR-
detection were not specific to ethanol. Co-
existing acetone, for example, had some
effect on analysis results (Sutton 1989).
Current evidential breath analyzers for
ethanol are more accurate and precise.
They are typically based on multiple-
wavelength IR-detection or a combination
of an electrochemical sensor and IR-
detection (Jones et al. 1996b, Lagois
2000). In the case of co-ingestion of
ethanol and another volatile solvent having
effect on ethanol analysis results, these
analyzers are designed to either reject the
ethanol analysis or subtract the erroneous
effect. None of these analyzers are
designed for identifying the interfering
component. The requirements for these
analyzers are registered in an international
recommendation (OIML 1998).
The simpler breath ethanol analyzers
are still used for screening purposes. Many
emergency departments have adopted
these breath meters for determining
bedside alcohol concentrations in
intoxicated patients. The clinical breath
alcohol testing should meet the same
quality-assurance and quality-control
requirements as any point-of-care test (Wu
AH et al. 2003).
Besides the original articles included
in this thesis, few studies have been
published on breath tests for poisoning due
to toxic alcohols or other intoxicating
solvents. Nishiyama and co-workers
(2001) examined an FT-IR analyzer for the
monitoring of solvent poisonings. In their
first (and so far the only published) study,
they studied ethanol intoxications in
volunteers. Breath acetone has been
measured by gas chromatography in
epileptic patients treated with ketogenic
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diets (Musa-Veloso et al. 2002), and
commercial breath acetone measurement
kits are available for dieting purposes
(Kundu et al. 1993).
Breath testing of employees in order
to determine occupational exposure has
been studied quite extensively, but it has
not yet found its way to routine biological
monitoring programmes (Wilson et al.
1999). The solvent concentrations in the
exhaled breath after an airborne exposure
diminish rapidly, and the remaining
“steady” concentrations are very low
(Liira et al. 1988, Lindstrom et al. 2002).
These low concentrations have been
measured mainly with gas chromatography
and mass spectrometry in laboratory
settings. Franzblau measured methanol in
ambient air and exhaled breath with an
FT-IR analyzer (Franzblau et al. 1992).
These (non-toxic) concentrations
correlated well with each other as well as
with blood concentrations. However,
measuring occupational exposure to
solvents in low concentrations falls out of
the scope of this thesis.
In conclusion, breath testing has
been previously used in solvent
intoxication diagnostics practically solely
for ethanol.
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3. Aims of the study
The general objective of the study was to develop an FT-IR breath test for solvent
intoxication diagnostics. The specific aims were:
1. To modify the hardware and analysis software of the Gasmet FT-IR analyzer for breath
testing.
(Studies I–III, V)
2. To evaluate the performance of the Gasmet FT-IR analyzer for solvent breath testing.
(Studies I, V)
3. To evaluate the feasibility of the Gasmet FT-IR analyzer in clinical settings.
(Studies I–III, V)
4. To evaluate the ability of Dräger Alcotest 7110 MK III FIN evidential breath ethanol
analyzer to reveal the presence of other intoxicating solvents.
(Study IV)
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4. The apparatus
4.1. Gasmet FT-IR analyzer
Study I was performed with a desktop
Gasmet FT-IR spectrometer (Temet
Instruments Oy, Helsinki, Finland). It was
equipped with a modified Genzel
interferometer (GICCOR, Temet
Instruments Oy, Helsinki, Finland) and a
multi-reflection gas cell. The breath
sample was collected directly into the 0.2
l gas cell heated to 50 °C (Figure 3). The
gas cell fittings were narrow (inner
diameter 4 mm), causing a considerable
resistance to blow. Prior to hitting the
detector, the IR radiation passed 2.0 m by
reflecting repeatedly from gold-coated
mirrors at both ends of the gas cell. The
material of the gas cell windows and the
beamsplitter was BaF2. The IR radiation
source was silicon carbide. A Peltier-
cooled MCT detector was operated in the
wave number range of 4,000–900 cm-1
(2.5–11 µm). All spectra were measured
at 8 cm-1 resolution and the scan rate was
10 scans/s.
A portable Gasmet FT-IR
spectrometer (Gasmet DX2000, Temet
Instruments Oy, Helsinki, Finland) was
used in the remaining four studies. It was
pilot-case-sized and weighed 18 kg. As a
distinction from the desktop model, this
point-of-care analyzer was equipped with
a Temet Carousel Interferometer (Temet
Instruments Oy, Helsinki, Finland), and
the cell fittings were widened (inner
diameter 9 mm), in order to reduce the
resistance to blow. During the study
conducted in the emergency rooms, the
device was placed on a pushcart for easy
bedside access and run on a 12 V battery.
Theoretically, an eight-hour analyzing
time was possible without charging. In
the other studies, the analyzer was
connected to mains.
Single-use bacterial filters (Pall
BB25, Pall Industries Ltd, CA, USA)
connected to the sampling hose were used
as a mouthpiece and to protect the
analyzer from contamination. The dead
space before the measuring cell
(consisting of the sampling hose and the
bacterial filter) was 60 mL.
4.1.1. Analysis software
Both of the Gasmet FT-IR analyzers were
equipped with multicomponent analysis
software (Calcmet, Temet Instruments
Oy, Helsinki, Finland). This software
quantifies the sample components simul-
taneously by using a modified classical
least squares fitting algorithm. It uses a
maximum amount of pre-computed
information to make the analysis simple
and fast (Jaakkola et al. 1997). The
analysis is based on Beer's law and
assumes that the absorbances of the
components in the gas phase are directly
proportional to their concentrations. The
multicomponent analysis algorithm
resolves the composition of the measured
unknown spectrum, using a set of single
component reference library spectra. The
baseline of the unknown spectrum is
generated mathematically to account for
baseline fluctuation (Jaakkola et al.
1997).
Figure 3. Gasmet FT-IR analyzer configu-
ration for breath testing.
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The residual spectrum is the
difference between the original sample
spectrum and the linear combination of
the single component library spectra in
concentrations determined by the analysis
results (Jaakkola et al. 1997). The
reliability of the analysis can be
characterized from the residual spectrum.
Ideally, it should be random noise
(Saarinen et al. 1991). A residual
spectrum different from random noise
may be due to a detectable sample
component not included to the reference
library (Saarinen et al. 1991). The
original FT-IR spectrum is automatically
recorded on the hard disk for possible
post-examination.
4.1.2. Preparation of the reference
library spectra (calibration)
Before each study, the Gasmet FT-IR
analyzer was inspected and calibrated in
cooperation with the manufacturer. The
infrared spectra of each single component
were measured in appropriate
concentrations and stored in the reference
library. Pro analysi grade reagents and
certified gases were used for calibration.
The reference library contained
several reference spectra for components
in varying concentrations throughout the
measuring range in order to minimize the
effect of possible non-linearity. The
Calcmet software is able to calculate the
non-linearity factors automatically during
the calibration process. This option was
used in the present study.
The reference spectra for liquids
were made by a Gasmet Calibrator
(Temet Instruments Oy, Helsinki,
Finland). It contained a syringe pump
(Cole-Parmer 74900 series, Cole-Parmer
Instrument Company, Vernon Hills,
Illinois, USA), a manual needle valve, a
mass flow meter (Aalborg GFM17,
Aalborg Instruments & Controls,
Orangeburg, New York, USA) and a
stainless steel injection chamber (Figure
4). The syringe pump injected precise
amounts of liquid into a heated N2 gas
flow in the injection chamber. Hamilton
25, 50 or 100µL syringes (Hamilton
1700-series, Hamilton Company, Reno,
NV, USA) were used depending on the
target concentration. The injected liquid
was vaporized rapidly, and a continuous
flow of a sample gas was produced. The
chamber was heated to temperatures 2 °C
below the boiling point of the component
in question. The maximum error in
preparing a reference dilution was
calculated to be ± 2.5% on the basis of
flow rate errors and injection rate errors.
Different reference concentrations
of gaseous substances (for example CO,
CO2, methane and butane) were prepared
by diluting certified reference gases with
nitrogen (Figure 5). The flow of gases
was controlled by Brooks SL5850 mass-
flow controllers (Emerson Process
management, Brooks Instrument,
Hatfield, PA, USA).
NV
Figure 4. Gasmet calibrator design. NV,
needle valve; FM, mass-flow meter.
REF
FT-IR
Figure 5. Generation of reference
samples for gaseous components.
REF, reference gas; F, mass-flow
controller; FT-IR, Gasmet FT-IR analyzer.
Heated lines are drawn in bold.
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4.1.3. Breath sampling procedure
Background measurements were
conducted with N2 or O2, because these
diatomic symmetric molecules do not
absorb IR-light. The background
measurement was carried out daily before
the measurement session.
Before each assay, the measuring
cell of the analyzer was flushed with
ambient air, and the analysis was
performed (0-sample). Paired samples of
exhaled breath were taken in order to
minimize random error. A carbon dioxide
concentration greater than 3 vol% was
used as a marker of alveolar sample.
Samples were accepted if the exhaled
CO2 was over 3 vol% and the variation
less than 10%. Sampling was repeated
when necessary. The sample with the
highest CO2 level was used in the final
analysis, except in the cases of methanol
intoxication, where the mean of the
samples was used.
Participants were requested to
inhale deeply and then blow the entire
lung volume through the analyzer’s gas
cell. Samples from unconscious patients
were collected by ventilating the patient
through the gas cell of the analyzer with a
revivator bag. The sample collecting
system can be fitted to an intubation tube
as well as a face mask (Figure 3, page
29). An alveolar sample was trapped in
the gas cell at the end of the expiration by
sealing off the collecting system with a
manual valve.
4.2. Dräger Alcotest 7110 MK
III FIN evidential breath
analyzer
An evidential breath analyzer has been
defined as an instrument which measures
the mass concentration of ethanol by
analyzing deep lung air, and is usable for
evidential purposes (OIML 1998). These
breath analyzers are designed to be able
to cope with an extra solvent without any
significant interference on ethanol
analysis. The Dräger Alcotest 7110 MK
III FIN evidential breath analyzer (Dräger
Safety AG & Co. KGaA, Lübeck,
Germany) was selected for the present
study, because it is the make used by the
Finnish Police. It will be referred below
as “Dräger 7110 evidential breath
analyzer”.
The Dräger 7110 evidential breath
analyzer is a semi-portable device which
is commonly kept at police stations. It
determines the breath alcohol
concentration using an electrochemical
sensor in addition to an infrared sensor.
The infrared sensor operates in the
wavelength of 9.5 µm, in order to avoid
the effect of acetone in particular. The
idea is that as two different measuring
systems are used, the analyzer is able to
detect an interfering component, discard
the analysis and display an “interfering
compound” message. Measurements are
considered acceptable only if the results
provided by both sensors are within tight
limits. (Lagois 2000)
In order to ensure the alveolarity of
the samples, only a small volume of end-
expiratory breath is required. Flow
sensors measure the volume of air blown
into the instrument and make sure that the
dead space air will not be analyzed. Two
temperature sensors record the
temperature of the exhaled airflow at the
mouthpiece end of the breath hose.
Results from the breath-ethanol analysis
are standardized to a fixed exhalation
temperature of 34°C. The analyzer
measures the ambient air ethanol
concentration and automatically checks
the calibration with a reference gas
sample in the course of each measuring
event. (Lagois 2000)
The Dräger 7110 evidential breath
analyzer was serviced and calibrated be-
fore the laboratory-testing in accordance
with the manufacturer’s instructions.
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4.3. Breath simulators
Two different types of breath simulators
were used in order to generate
standardized samples for the evaluation of
the analyzers’ properties.
4.3.1. Bubbling system
For ideal dilute solutions, Henry's law
predicts a linear relationship between the
partial vapour pressure of the solute and
its concentration in the aqueous phase. A
gaseous sample containing water vapour
and a solvent was generated by bubbling
nitrogen gas through a water-solvent
mixture. The nitrogen flow was controlled
by a Brooks SL5850 mass-flow controller
(Figure 6). In addition to a mixture of a
single component in water, dilute
mixtures of two or more solvents in water
were also prepared. The temperature of
the liquid and ambient air was monitored.
These samples contained water vapour in
biological amounts (3.0 vol%), but
differed from human breath by containing
no carbon dioxide.
4.3.2. Calibrator system
Due to the possibility that chemical
interference in the liquid phase may affect
the vaporization in the bubbling system, a
calibrator system was developed for
breath simulation.
The calibrator system consisted of
two parallel Gasmet Calibrators and a
water bubbling system (Figure 7). A close
imitation of exhaled breath was achieved
by using 5 vol% carbon dioxide in
nitrogen as a carrying gas (AGA, Espoo,
Finland). Water was vaporized into the
system by bubbling CO2-N2 gas through
water warmed to 37 °C. The final sample
water vapour content was 2.5 vol%.
Ethanol or methanol and possible
interfering compounds were injected to
the system from separate calibrators in
order to avoid the possible interference in
the liquid phase. In order to avoid
swaying in the final sample concentration,
the syringe pumps were operated at a high
speed and the sample gas was conducted
through a heated 1.0 l integrator. The
final concentration of the sample
components was calculated on the basis
of the injection rates and the total gas
flow.
Figure 6. Breath simulator based on a
bubbling system. F, mass-flow controller;
FT-IR , Gasmet FT-IR analyzer. Heated
lines are drawn in bold.
Figure 7. Breath simulator based on
calibrators. C, Temet calibrator; F, mass-
flow controller, 1.0 L, heated integrator;
FT-IR, Gasmet FT-IR analyzer.
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5. Study subjects
Six hundred and fifty-eight persons
participated in the studies. The demo-
graphics of the study subjects are shown in
Table 4. All of the study subjects were
informed about the study protocol, and
they gave their informed written or verbal
consent. In cases of unconsciousness, the
consent was obtained from the patient’s
relatives. No reward was given to any of
the study subjects.
5.1. Ethical considerations
The Ethics Committees of the Depart-
ments of Medicine at Helsinki University
Central Hospital and at Tampere
University Hospital approved the study on
methanol intoxications (96/1997 and 26
Aug 1997, respectively). The Ethical
Committee of the Hospital District of
Helsinki and Uusimaa approved the study
conducted at the emergency rooms
(5/2000). The Study Committee of the
Social Services Department of the City of
Helsinki approved the breath testing of the
inebriated homeless men (18 May 1998
and 7 Sep 1999).
Table 4. Study subjects
Study Number Sex Age Comatose Informed Interventions Main study
subjects participated m / f median consent purposes
(Study) (refused) (range)
Healthy
volunteers
9 9 / 0 32
(29–47)
0 written Ethanol
per os
Modifying the
hardware
(I, V) Breath tests
Blood tests
Evaluating the
performance
Methanol
intoxications
6 6 / 0 41
(31–60)
5 written Breath tests
Blood tests
Evaluating the
feasibility
(II) Evaluating the
performance
ER patients
(III)
609
(146)
286 / 323 44
(15–96)
4 written Breath tests Screening the
breath volatiles
Evaluating the
feasibility
Evaluating the
performance
Inebriated
homeless
men
35 35 / 0 50
(35–65)
0 verbal Breath tests Screening the
breath volatiles
(V) Evaluating the
feasibility
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6. Study protocols
6.1. Modifying the Gasmet FT-IR
analyzer for breath testing
The Gasmet FT-IR gas analyzer was
initially intended for the analysis of
industrial exhaust fumes (Ahonen et al.
1996), not for breath testing. During the
study period, both the hardware and
software of the analyzer were modified for
breath testing purposes.
6.1.1.1. Analyzer hardware
Prior to the initiation of the studies, the
size of the gas cell was reduced from 1 l to
0.2 l in order to achieve alveolar samples.
The patient interface was constructed from
a simple plastic hose and a bacterial filter
used in the anaesthesia circuits (Figure 3,
page 29). The impact of the sampling
system components on the results of the
analysis was evaluated in a few small
experiments.
6.1.1.2. Gas cell size
As the sample is blown to the measuring
cell, it becomes turbulent and gradually
displaces the gas previously existing in the
cell. The gas changing in the cell was
investigated by leading nitrous oxide (0.5–
1 l/min) into the gas cell previously
flushed with plain nitrogen (unpublished
data). Simultaneous non-stop FT-IR
measurements were carried out to
determine the sufficient volume in which
the gases could be adequately exchanged.
Further tests were conducted with a
Datex S/5 anesthesia monitor (Meriläinen
et al. 1993) in order to determine the
exhaled gas behaviour in the measuring
cell during authentic breath sampling
(unpublished data). A healthy volunteer
subject (male, 40 yrs, 192 cm, 90 kg) gave
breath samples. The flow, pressure and
carbon dioxide concentration were
measured simultaneously at 0.1 s intervals
before the bacterial filter and at the outlet
of the measuring cell. The carbon dioxide
concentration of nine good-quality
exhalations was averaged in relation to
exhaled volume. The gas mixing in the
sampling system was estimated on the
basis of the difference in the carbon
dioxide concentration at the two measur-
ing points.
6.1.1.3. Gas cell fittings
The fittings for the new portable version of
the analyzer were made markedly wider
(inner diameter 9 mm) in order to decrease
sample flow resistance. A specific study
was performed to measure the effect of the
sample flow resistance on the results of the
analysis (Study I). In the beginning of the
protocol, the test subject (male 32 yrs, 192
cm, 87 kg) ingested a weight-adjusted
dose of ethanol in grapefruit soda (final
ethanol concentration 20 vol%) in 10
minutes to achieve a blood ethanol
concentration of 1 g/l. Measurements
started immediately after the ingestion of
the ethanol and lasted until the late
postabsorptive phase. Four different
resistance levels were generated by
blocking the outlet opening so that the
resulting mean pressures during sampling
ranged from 1.3 kPa (13 cmH2O, full
open) to 4.1 kPa (41 cmH2O, correspond-
ing to the opening in the previous version).
6.1.1.4. Filter and sample hose
Unheated hosing is a condensation focus
for warm exhalation saturated with water.
The filter is intended to protect the
analyzer from particles and bacteria, but it
might also trap some water vapour. The
effect of the hosing and the bacterial filter
on the results of the water, CO2 and
ethanol analysis was determined in an
experiment with one volunteer (male 40
yrs, 192 cm, 90 kg, unpublished data). The
subject blew repeated samples, either
directly to the cell or through the filter and
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hose. The effect on ethanol results was
tested in the postabsorptive phase after the
volunteer had ingested a weight-adjusted
dose (0.6–0.8 g/kg) of ethanol in grapefruit
soda.
6.1.2. Analysis software settings
The adjustment of the analysis software
settings included the selection of the
appropriate components into the reference
library and of the suitable analysis options
for each of the components.
Hundreds of breath tests were run to
find out the most significant breath
components detectable by the Gasmet FT-
IR analyzer, and also to determine their
concentration distribution in the Finnish
population. Exhaled breath was
systematically screened in two important
populations: patients attending the
emergency rooms and men intoxicated
with technical ethanol products (Studies
III, V). On the basis of the data collected,
the detectable normal breath components
and possible exogenous solvents were
selected into the reference library.
The whole FT-IR spectrum in the
wave number range of 4,000–900 cm-1 was
not used for the analysis. The regions of
the spectrum used were selected for each
component separately. The principle was
to select regions containing the typical
absorption bands of the component and to
avoid the regions of extensive absorbance
of the bulk components (water and carbon
dioxide). To ensure the linearity of the
analysis, the regions with saturated
absorption peaks were not selected. In
addition, the software was configured to
automatically ignore absorbance peaks
over the limit defined by the user (mostly
0.4 absorbance units).
6.1.2.1. Screening the breath of patients
attending emergency rooms
All of the patients attending the emergency
rooms (ER) were included in the study,
with the exception of children under 15
years of age. This study was carried out in
two hospitals and two municipal health
care centres in Hyvinkää and Porvoo,
Finland. The study was performed in eight
or sixteen-hour periods appropriately
distributed to cover every hour of one
week. These periods were spread over
eight weeks from September to November
2000, avoiding public holidays.
During the study period, the 609
participants were inquired about their
reason for coming to the ER, alcohol
usage, and smoking habits. Height, weight,
sex and age were recorded. The breath test
was performed as soon as possible after
the admission. The analyzer was run on a
battery, and it was brought to the bedside
for breath sampling. Before each assay, the
measuring cell of the analyzer was flushed
with ambient air, and the analysis was
performed (0-sample). Paired samples of
exhaled breath were taken. The sample
with the highest CO2 level was used in the
final analysis.
6.1.2.2. Breath testing after ingestion of
technical ethanol products
Thirty-five men living in a dormitory
supported by the City of Helsinki were
included. Most of these men had
consumed low-priced technical ethanol
products, such as windshield washer fluids
and cooker fuels. The breath tests were
performed in order to determine the
special characteristics of exhaled breath in
this population. Forty-six breath tests were
run during five afternoons in 1998 and
2000 (three men participated three times
and five twice).
The participants were interviewed
for the type of ethanol products used as
well as for their medical conditions and
current medication. Their height, weight
and the time of the latest proper meal were
recorded. The study was conducted in a
dormitory on Sahaajankatu, Helsinki,
Finland.
The breath sampling was carried out
according to the procedure described
above. As a rule, 10 to 30 minutes had
elapsed between the latest alcohol dose
and breath testing. Ethanol vaporizing
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from the mucous membranes of the mouth
due to prior drinking was accounted for by
taking two or more breath samples. A
rapid decrease in breath ethanol in
subsequent measurements would have
revealed a mouth alcohol effect. The
breath test results were not correlated with
blood concentrations, because appropriate
conditions for controlling the volume of
the solvent and time of ingestion were not
available.
6.2. Evaluating the performance
of the Gasmet FT-IR analyzer in
solvent breath testing
It is generally accepted that at least the
following parameters should be evaluated
for quantitative procedures: calibration
model (linearity), accuracy (bias,
precision), limit of quantification
(sensitivity), selectivity and stability
(Peters et al. 2002).
6.2.1. Calibration model (linearity)
Linear range is the interval between the
upper and lower concentration of the
analyte in the sample (including these
concentrations) for which it has been
demonstrated that the analytical procedure
has a suitable level of precision, accuracy
and linearity (Shah et al. 2000).
The calibration model and linearity
of the Gasmet FT-IR analyzer is based on
Beer’s law. To confirm the linearity, nine
ethanol and eight methanol reference
spectra were prepared with the Temet
calibrator (Study I). The measurement
time was 3 minutes, according to the
normal calibration procedure. The
reference concentrations ranged from 22 to
2,010 ppm for ethanol and from 33 to
2,000 ppm for methanol. The largest
absorbances for ethanol (at 1049 cm-1,
9.533 µm) and methanol (at 1057 cm-1,
9.461 µm) were measured manually from
the IR-spectra. The linear regression line
equation between the absorbance and the
vapour concentration was calculated. The
residuals were examined to verify the
linear fit (unpublished data).
In order to avoid measuring the
absorbance at high, non-linear absorbance
levels, the linearity check was later
repeated at 2,972 cm-1 (3.365 µm) for
ethanol and at 2,979 cm-1 (3.357 µm) for
methanol (unpublished data). The
concentration range was 10 to 960 ppm for
ethanol (5 steps) and 10 to 1,440 ppm for
methanol (6 steps).
To verify the validity of the linear
calibration model in the matrix of human
breath, simulated breath samples spiked
with ethanol were generated with the
calibrator system (Study I). Four samples
at each of the six levels (from 144 to 1733
ppm) of ethanol were analyzed. An
automated spectral analysis protocol
(Calcmet analysis software) was used
instead of manually measuring the peaks
from the FT-IR spectrum. The linear
regression line equation between the
analysis results and the theoretical vapour
concentration was calculated. The
residuals were examined to verify the fit
(unpublished data).
6.2.2. Accuracy
Accuracy is defined as the degree of
closeness of the determined value to the
nominal or known true value under
prescribed conditions (Shah et al. 2000). It
consists of random and systematic error
components, i.e., precision and bias.
The precision expresses the
closeness of agreement (degree of scatter)
between a series of measurements
obtained from multiple sampling of the
same homogenous sample under the
prescribed conditions. In the present study,
the precision was divided into within-day
and between-day repeatability. The
precision was calculated according to
Bookbinder and co-workers (1986)
(Equation 10.8).
The bias is defined as the difference
between the expectation of the test results
and an accepted reference value (Shah et
al. 2000). It is caused by one or more
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systematic error components. The bias of
analysis results was calculated for ethanol
and methanol (Equation 10.9).
Samples for the preliminary accuracy
testing were made by the bubbling
method, at 21 ± 1 ºC, 1 atm (Study I). Nine
ethanol and ten methanol water solutions
were prepared. The ethanol and methanol
concentrations in the liquid ranged from
0.2 to 32 g/l and 0.1 to 32 g/l, respectively.
The measurement time was 1 minute, and
each sample was analyzed 10 times. The
precision and bias of the Gasmet FT-IR
analysis results were determined by
comparing the results with the expected
values calculated according to the median
of the Henry’s law literature values
(Sander 1999).
Linear regression equations were
calculated for the relationship between the
analysis results and the liquid
concentrations. The coefficient of this
equation was further converted into the
units of Henry’s law. The values obtained
were compared to the values in the
literature (Table 3, page 21).
The precision and bias of ethanol and
methanol analyses were further
investigated by analyzing simulated breath
samples generated with the calibrator
system (Study V). The results of the
analysis were compared with the
theoretical nominal values calculated on
the basis of the calibrator system settings.
The precision and bias were determined on
ethanol levels of 150–1,730 ppm [0.27–
3.17 mg/l] and on methanol level of 50
ppm [63 µg/l]. Four to sixty-six one-
minute measurements were conducted on
each level.
6.2.3. Sensitivity
The sensitivity of an analytical method is
described in terms of the limit of detection
(LOD) and the lower limit of
quantification (LLOQ). The limit of
detection is determined as the lowest
concentration of an analyte which the
bioanalytical procedure can reliably
differentiate from background noise. The
lower limit of quantification is determined
as the lowest amount of an analyte in a
sample which can be quantitatively
determined with suitable precision and
accuracy (Shah et al. 2000). The limits of
detection for ethanol and methanol were
determined in laboratory settings by
analyzing plain matrix (Equation 10.10).
In Study I, the analyzed matrix
contained either pure nitrogen or nitrogen
with 3.0 vol% water vapour. The samples
were prepared by leading a N2 flow
through the measuring cell or by using the
bubbling method (for generating the water
vapour). Thirty one-minute measurements
were carried out at 21.0 ± 1.0 °C, 1 atm.
The limits of detection and the lower
limits of quantification for fourteen
components were systematically further
determined in laboratory settings in five
different matrixes: plain nitrogen,
simulated breath (water vapour 2.5 vol%
and CO2 5.0 vol% in N2), simulated breath
spiked with 500 ppm ethanol or 500 ppm
methanol, and simulated breath spiked
with 440 ppm ethanol, 250 ppm acetone,
41 ppm 2-propanol, 53 ppm MEK and 24
ppm MIBK (Study V). The latter mixture
resembles exhaled breath after the
ingestion of Marinol-100 (cooker fuel,
Berner ltd, Helsinki, Finland). In addition
to ethanol (over 80% w/w), Marinol-100
contains MEK (2% w/w), MIBK (2%
w/w) and 2-propanol (1%–5% w/w)
(Berner 2005). The samples were
generated with the calibrator system.
Thirty samples of each mixture of
components were analyzed, and LOD and
LLOQ were calculated for the components
not present in the matrix.
6.2.4. Selectivity
Selectivity is defined as the ability of a
bioanalytical method to measure
unequivocally and differentiate the
analyte(s) in the presence of components
which may be expected to be present.
Typically, these might include metabolites,
impurities, degradants, matrix
components, etc. (Shah et al. 2000).
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Interference is considered unacceptable
when it affects the accuracy of
quantization at concentrations to the extent
that it may result in erroneous study
conclusions. Small interferences can be
accepted as long as precision and bias
remain within certain acceptable limits
(Dadgar et al. 1995).
The selectivity of the Gasmet FT-IR
analyzer was preliminarily evaluated by
determining the effect of ethanol on
methanol analysis (Study I). The study
was conducted in laboratory settings with
the bubbling method at 21.0 ± 1.0 °C, 1
atm. The effect of high ethanol
concentration (300 ppm in vapour) on the
results of methanol analysis was tested at
seven methanol levels ranging from 14 to
2,000 ppm in vapour. The bias caused by
the matrix ethanol was calculated for each
concentration level by comparing the
results of the methanol analysis with
ethanol to those without ethanol. Ten one-
minute measurements were run at each
analyte level.
The selectivity of the analyzer for
ethanol and methanol was investigated
more systematically at clinically
significant concentrations in a matrix
resembling human breath (Study V). The
sample was spiked with a number of
possible interferents, one at a time.
Samples were prepared with the calibrator
system. The concentration of ethanol in
the simulated breath was set to 150 ppm
[0.27 mg/l] in order to be close to the legal
DUI limit. The sample methanol
concentration was set to 50 ppm [63 µg/l].
It corresponds with a blood concentration
of 6.1 mmol/l, when a blood-breath ratio
of 3,063 is applied (Study II) (Ellenhorn
1997). In order to determine the possible
effect on analysis results, three one-minute
measurements were taken before and after
adding the interfering compound. At least
two concentration levels of each
interferent were investigated. The
interferent concentrations used mostly
exceeded their highest likely levels in
humans. The bias caused by the interferent
in the matrix was calculated for each
concentration level by comparing the
results of the analysis for ethanol or
methanol with the interferent to those
without an interferent (= nominal value).
The procedure was performed twice for
each interferent concentration level. Mean
bias was calculated from the results of the
six measurements. The overall effect of
compounds tested was evaluated by
calculating the average absolute bias
(Equation 10.11).
6.2.5. Stability
Stability means the chemical stability of an
analyte in a given matrix under specific
conditions for given time intervals (Shah
et al. 2000). The stability was evaluated by
keeping a breath sample in the measuring
cell for three hours and analyzing it
repeatedly (Study V). In addition to
normal breath components, the sample
contained 100–1,000 ppm [0.2–1.9 mg/l]
ethanol. During the test, the manual valve
was closed and the sampling hose
connected to the analyzer.
6.3. Evaluating the feasibility of
the Gasmet FT-IR analyzer in
clinical settings
Toxicological thresholds for intoxicating
solvents are mainly determined as blood
concentrations. Therefore, the solvent
breath tests are mostly used for estimating
blood concentrations of intoxicating agents
instead of using the exhaled concentrations
per se. Several patient-related factors in
the respiratory system and blood
circulation affect the gas exchange
between the blood and exhaled breath,
which may cause misinterpretation of the
results of the analysis, regardless of the
accuracy of the breath analysis method.
Simultaneous blood and breath samples
were taken in Studies I and II in order to
evaluate the feasibility of the Gasmet FT-
IR analyzer in the clinical settings. The
principal aim of the studies was not to
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investigate the blood-breath transport of
volatile compounds.
6.3.1. Correlation of blood and breath
concentrations
In Study I, six healthy volunteer subjects
were tested. They fasted for three hours
before the experiment. At the beginning of
the protocol, each of the men ingested a
weight-adjusted dose (0.6–0.8 g/kg) of
ethanol in grapefruit soda (final ethanol
concentration 200 ml/l) in 10 minutes to
achieve a blood ethanol concentration of 1
g/l. After the ingestion, the subjects’
mouths were rinsed with water, and 8–28
minutes elapsed before sampling. Breath
and venous whole blood samples were
taken at three points: blood ethanol
concentration 1) rising (absorption phase),
2) at its peak (plateau phase), and 3)
declining (postabsorptive phase). At each
point, a blood sample and three breath
samples were taken. Whole blood ethanol
concentration was measured with
headspace gas-liquid chromatography.
In Study II, the objective was to
catch all methanol intoxication patients
treated at Helsinki University Central
Hospital and Tampere University Hospital
during the study period from April 1998 to
June 1999. Repeated blood and breath
ethanol and methanol samples were taken
from six male patients. The first breath
samples were taken 1.5–12 hours after the
arrival of the patient. Further breath
samples were taken at 15–30 min intervals
during the treatment. Blood samples were
taken simultaneously with breath samples
whenever the concentration of methanol
had changed considerably. Whole blood
ethanol and methanol concentrations were
measured with headspace gas-liquid
chromatography.
The suspected linear blood-breath
correlation based on Beer’s and Henry’s
laws was evaluated in clinical settings by
calculating a linear regression line for the
pairs of blood and breath ethanol and
methanol measurements. Relative
residuals were observed to evaluate the
goodness of the linear fit. In addition, a
blood-breath ratio was calculated for
ethanol and methanol (Equation 10.1). The
accuracy of the clinical analysis results
was estimated by comparing the blood-
breath ratios to the values in the literature.
6.3.2. Sampling and analyzing
The transportability, robustness and
easiness of use of the analyzer have been
evaluated by the study team throughout the
entire study period. The easiness of use
was evaluated more specifically during
Study III. Four nurses with no previous
laboratory experience were employed as
study assistants to take the breath samples.
Before the study, they had a two-hour
training session. The nurses were inquired
about the easiness of the sampling in each
of the 609 patients’ data form.
6.4. Evaluating the ability of
Dräger 7110 evidential breath
analyzer to reveal the presence
of other intoxicating solvents
Breath testing is widely used to determine
the degree of ethanol intoxication. Dräger
7110 evidential breath analyzer’s response
to a solvent other than ethanol was
investigated to discover if any hint could
be achieved in the case of co-ingestion of
toxic solvents (Study IV). This study was
carried out at the Laboratory of Physical
Chemistry at the University of Helsinki.
Simulated breath samples were
generated with the calibrator system
(Chapter 4.3.2). The ethanol
concentrations used in this study were
determined according to the legal breath-
ethanol concentration limits for DUI
(driving under the influence) enforced in
Finland at that time: 0.25 mg/l (drunken
driving) and 0.60 mg/l (aggravated
drunken driving).
Eight potentially interfering solvents
were selected for in vitro testing: acetone,
methanol, 1-propanol, 2-propanol, methyl
ethyl ketone, methyl isobutyl ketone,
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diethyl ether and ethyl acetate. Prior to the
measurement with an interfering solvent,
plain ethanol was measured in simulated
breath in order to calculate the specific
interference effect. The concentration of
the interfering compound was raised until
the “interfering compound” message was
displayed, and the analysis was rejected.
The Gasmet FT-IR analyzer was attached
to the system to indicate stable
concentrations before measurements with
the Dräger 7110 evidential breath ethanol
analyzer. Measurements at threshold levels
were repeated with the intention of
reducing random errors.
In addition to the absolute and
relative errors in the results of the ethanol
analysis at the maximal interferent level,
coefficient Cx was determined to describe
the biasing power of an interfering
compound (Equation 10.12).
6.5. Statistical analyses
The Mann-Whitney U test was used to
compare two groups with non-normal
distribution (age: participants with
successful breath samples vs. participants
with failed breath samples, Study III). The
Student’s t-test was used to compare two
groups with normal distribution (exhaled
CO in non-smokers: men vs. women,
Study III).
The Kruskal-Wallis test was
employed to compare multiple groups with
non-normal distribution (proportion of
methane producers: multiple groups
classified according to age, sex, smoking
and gastro-intestinal disease, Study III).
Analysis of variance (ANOVA) was used
to compare multiple groups with normal
distribution (exhaled CO in smokers:
multiple groups classified according to the
time of the latest cigarette and the number
of cigarettes smoked per day, Study III).
The ANOVA was also used for precision
calculations (Study V).
Linear regression line equations and
squared Pearson correlation coefficients
(R2) were calculated to estimate linear
relationship between two parameters (e.g.,
blood and breath methanol concentration
in Study II). To evaluate the scatter of the
results around the linear fit, the residuals
were observed and relative standard
deviation calculated.
Positive and negative predictive
values were calculated for a CO breath test
designed to differentiate smokers from
non-smokers (Study III). Single Grubb’s
test was employed to identify outliers in
the linearity test (Study V).
The statistics were calculated with
SPSS for Windows and MS Excel
software. P < 0.05 was considered statisti-
cally significant.
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7. Results
7.1. Configuration of the Gasmet
FT-IR analyzer for breath testing
The use of a low-resolution FT-IR method
for breath testing had not been reported
previously. In the beginning of the study
period, the Finnish and European patents
were applied for. They were granted in
2004 and 2006, respectively (Himberg et
al. 2004, 2006).
7.1.1. Impact of sampling system
components on analysis results
According to the N2O test, the volume
required for a more than 90% or 95%
change in the cell gas was 0.4 l or 0.5 l,
respectively.
When CO2 was measured before and
after the cell during an authentic breath
sampling, there seemed to be a 0.4–0.7 l
difference in the steep part of the CO2
curves (Figure 8). This difference
represents the volume required to
exchange the gas in the sample hose and
the measuring cell. A CO2 concentration
of over 3 vol% behind the cell was reached
when 1.5 l was exhaled. The CO2
concentration of 3 vol% corresponded
with 70% of the maximum CO2
concentration measured before the
bacterial filter.
The patient-analyzer interface of the
early version was not satisfactory.
Blowing into the gas cell with 4 mm
fittings caused a more than 30 cmH2O
pressure (peak pressure over 40 cmH2O),
while the flow remained mostly below 15
l/min. The mean volume exhaled was 4 l
and the mean duration of blowing 20 s.
Blowing into the gas cell with 9 mm
fittings was considerably easier than with
the previous version. The sample flow
even exceeded 100 l/min, and the pressure
remained mostly below 1.5 kPa. The
exhaled ethanol concentration measured
did not change even though different
resistance levels were generated by
blocking the outlet opening. The
concentration of CO2, however, increased
from 3.1 to 4.2 vol%, as the increasing
resistance induced a longer blowing time
(3.4 s and 8.3 s, respectively).
bacterial filter
35 mL
sampling
hose
25 mL
2nd CO and
flow meter
2
1st CO and
flow meter
2
Figure 8. The increase in the carbon dioxide concentration during breath sampling. The CO2
and flow was measured by Datex S/5 anaesthesia monitor during nine exhalations and
averaged. The upper line represents the measurements before the filter and the lower in the
outlet of the measuring cell.
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The effect of an unheated 50 cm
sampling hose and bacterial filter on the
results of the analysis for water, carbon
dioxide and ethanol is shown in Figure 9.
The nominal ethanol concentration varied
from 199 to 250 ppm due to absorption
and metabolism during the study.
7.1.2. Reference library composition
and analysis software settings
During the studies, we selected a
reasonable combination of library
components for solvent breath testing as
well as the best analysis regions for each
of them. The most up-to-date combination
of the reference library components, their
IR spectra and the wave number ranges
used in the analysis are shown in Figures
10 and 11. The results of the two breath
screening experiments are described in the
following.
%
Figure 9. The relative effect of filter and
sampling hose on breath analysis results
[%]. Means and 95% confidence intervals
for the means are displayed. Concentra-
tions without filter and hose are shown on
the top of the figure.
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Butane and toluene
Ethanol, methanol, 1-propanol,
2-propanol, Acetone, MEK,
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Figure 10. An FT-IR spectrum of a breath sample after ingestion of Marinol-100, which
contains ethanol. methyl ethyl ketone, methyl isobutyl ketone and 2-propanol. The bars under
the spectrum represent the wave number range used in the analysis of the breath
components.
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Figure 11. FT-IR spectra and chemical structures of the reference library components.
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7.1.2.1. Breath composition of patients
attending emergency rooms
The concentration distributions of the
main detected components are shown in
Figure 12.
The self-reported smoking rate
among participants was 36.3%. Exhaled
CO of more than 4 ppm [4.5 µg/l] had a
positive predictive value of 0.92 and
negative predictive value of 0.96 for
smoking. Among smokers, the time
elapsed from the latest cigarette best
explained the variation in exhaled CO
(ANOVA: p < 0.01, R2 = 0.23). No CO
intoxications occurred during the study.
The proportion of patients exhaling
more than 2 ppm [1.3 µg/l] of methane
over the ambient air concentration
(methane producers) was 31.6%. Age was
the best predictor of exhaled methane.
Increasing age was associated with a
greater proportion of methane producers
and a higher absolute exhaled methane
concentration (Kruskal-Wallis test: p <
0.01). Sex, smoking and acute gastro-
intestinal disorder all became non-
significant factors after age consideration.
Acetone (0.7 ppm or over) was
detected in the breath of 298 participants.
Elevated exhaled acetone (10–76 ppm
[23–175 µg/l]) was detected in ten
patients.
A patient exhaling more than 25 ppm
[46 µg/l] of ethanol, corresponding with
more than 0.1 g/l in blood, was classified
as “ethanol positive”. Fifty-four (9.5%)
patients were ethanol positive. With night-
time admissions, 30% of all and 63% of
trauma patients tested ethanol positive.
Men were ethanol positive 3.7 times more
frequently than women. The ethanol
concentrations measured were high:
median exhaled ethanol concentration was
435 ppm [795 µg/l], corresponding with a
blood ethanol concentration of 2.0 g/l.
Methyl ethyl ketone (66 ppm [189
µg/l]) was detected in one breath sample.
This patient had used windshield washer
fluid (Lasol 100, Berner ltd, Helsinki,
Finland). No other intoxicating solvents
were detected.
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Figure 12. Concentration distribution of the main breath components among emergency
room patients. Open columns represent the results below the detection limit. The methane
concentration displayed is the difference between concentrations in exhaled and ambient air,
which is the reason for the negative values.
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7.1.2.2. Composition of the breath after
ingestion of technical ethanol products
Acetone, 2-propanol, methyl ethyl ketone
and methyl isobutyl ketone were the most
abundant solvents found in the breath, in
addition to ethanol (Table 5). Breath
acetone concentrations were high and
correlated linearly with 2-propanol con-
centrations (Figure 13). The acetone con-
centration even exceeded the toxic limit in
four samples. Sub-toxic amounts of ex-
haled 2-propanol were detected in 33 out
of 46 samples. The concentrations of other
solvents were toxicologically insignificant.
Twenty-four (69%) of the men were
methane producers (methane >10 ppm [6.4
µg/l]). Ambient air methane was 1.5 to 2
ppm. Carbon monoxide was over 4 ppm
[4.5 µg/l] in 39 of the samples (85%),
indicating a smoking habit.
Table 5. Composition of the breath after ingestion of technical ethanol products.
Component Concentration
median maximum
[vol%] [vol%]
Carbon dioxide 4.1 5.3
Water 2.5 3.4
[ppm] [µg/l] [ppm] [µg/l]
Methane 18 11 79 50
Carbon monoxide 12 13 32 36
Acetone 101 233 347 800
Ethanol 427 781 918 1677
Methanol < LLOQ 9.9 13
1-propanol < LLOQ 13 31
2-propanol 18 43 56 134
Butane < LLOQ 6.0 14
MEK 28 80 88 253
MIBK 5.5 22 47 187
MTBE 1.9 6.6 5.3 19
Toluene < LLOQ 2.2 8.0
Diethyl ether < LLOQ 1.0 3.0
Ethyl acetate 0.7 2.4 2.6 9.1
< LLOQ = under the lower limit of quantification determined in simulated breath spiked with 500 ppm EtOH;
MEK = methyl ethyl ketone; MIBK = methyl isobutyl ketone; MTBE = methyl tert-butyl ether
Figure 13. Correlation of acetone and 2-
propanol concentrations in the 34 breath
samples with values over the lower limit of
quantification. The line represents linear
regression.
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7.2. Performance of the Gasmet
FT-IR analyzer in solvent breath
testing
7.2.1. Calibration model (linearity)
The correlation between concentrations of
ethanol (EC, ppm) or methanol (MC, ppm)
and the corresponding largest absorbances
at 1049 cm-1 (9.533 µm) for ethanol (EA,
absorbance units) or 1,057 cm-1 (9.461
µm) for methanol (MA, absorbance units)
were practically linear: EA = 3.53×10-
4×EC – 8.30×10-4, r2 = 0.9990; MA =
4.12×10-4×MC + 6.37×10-3, r2 = 0.9993
(Figure 14). The relative residuals ranged
from -5% to +11% for ethanol and from -
33% to +4% for methanol. Observation of
the residuals revealed one outlier among
the ethanol measurements (verified by
Single Grubb’s test, α = 0.01) and a slight
non-linearity (convexity) in the methanol
measurements. When the outlier was
excluded from the ethanol regression
calculations, the correlation was: EA =
3.56×10-4×EC + 6.12×10-5, r2 = 1.0000,
and the relative residuals for ethanol were
±2% (the outlier was -6.5%).
The correlation between the
calculated (EC, ppm) and measured (EM,
ppm) ethanol concentration in the samples
of simulated breath was quite linear: EM =
1.02×EC – 6.3, r2 = 0.9992. Observation of
the residuals revealed quite extensive
variation in the highest level of ethanol,
but no deviation from the linear
relationship. The mean relative residuals
varied from -3.3% to 1.0%.
Figure 14. Linear calibration model. The lines in upper diagrams represent the linear
regression lines for correlation between liquid concentration and the IR-absorbance. The
lower diagrams show the absolute and relative residuals.
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7.2.2. Accuracy
The literature values for Henry's law
constants (corrected to 21 °C, 1 atm)
ranged from 216 to 311 M/atm (median
257) for ethanol and from 266 to 292
M/atm (median 285) for methanol (Sander
1999). According to our bubbling tests, the
Henry’s law constant was 235 M/atm for
ethanol and 243 M/atm for methanol. Our
values were 9% and 15% smaller than the
median values, respectively.
The bias in the preliminary accuracy
testing (the bubbling tests) ranged from
10.9% to 16.9% for ethanol and from
10.6% to 24.6% for methanol. The within-
day coefficient of variation for the ten
measurements at each level ranged from
0.1% to 1.1% for ethanol and from 0.4%
to 1.0% for methanol.
The bias of the analysis results was ±
2% for ethanol and -11% for methanol
(Figure 15), when simulated breath
samples generated with the calibrator
system were analyzed. Within-day and
between-day coefficients of variation were
< 1% for ethanol and < 4% for methanol
(Table 6).
7.2.3. Sensitivity
According to the bubbling tests, the limits
of detection were 0.9 ppm and 1.2 ppm
[1.7 and 2.3 µg/l] for ethanol and 0.9 ppm
and 1.3 ppm [1.2 and 1.7 µg/l] for
methanol in N2 matrix and N2 + 3.0 vol%
water matrix, respectively.
The detailed results of the systematic
sensitivity tests with the calibrator system
are shown in Table 7. When compared to
plain N2 matrix, the addition of water and
carbon dioxide to the matrix caused
marked elevation in the LODs and
LLOQs. The LOD and LLOQ for tested
components in plain simulated breath
ranged from 0.2 to 2.4 ppm [0.5 to 6.8
µg/l] and from 0.5 to 6.5 ppm [1.7 to 12
µg/l], respectively.
7.2.4. Selectivity
In the preliminary bubbling tests, the
calculated bias of the methanol analyses
due to the presence of ethanol ranged from
-2.7% to +1.4%, the average absolute bias
Table 6. Summary of the analytical precision studies.
Component Nominal Number Analyses Measured Within-day Between-day Total
conc. of days per day conc. SD2 CV (%) SD2 CV (%) SD2 CV (%)
(ppm) (ppm)
Ethanol 150 5 9 148 1.4 0.8 1.6 0.9 3.0 1.2
Methanol 50 3 12 44 2.4 3.5 0.5 1.6 2.9 3.8
SD2 = variation
CV = coefficient of variation
420-2-4-6-8-10-12-14
EtOH 1730 (66)
EtOH 1160 (9)
EtOH 870 (8)
EtOH 580 (10)
EtOH 350 (4)
EtOH 150 (4)
MeOH 50 (45)
Figure 15. Bias [%] of analysis results in
simulated breath. Vertical axis: ethanol or
methanol concentration in ppm. Boxes
represent the means and lines the 95%
confidence intervals of means. The
number of measurements is displayed in
brackets.
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was 1.7%. The high ethanol concentration
in the sample did not markedly affect the
linear correlation between liquid and
measured vaporous methanol
concentrations. The effect to the
correlation coefficient was only -1.4%,
when compared to the value without
ethanol.
The effects of various solvents on
ethanol and methanol analyses in
systematic tests with the calibrator system
are displayed in Table 8 (page 50). The
absolute effect on ethanol and methanol
readings ranged from -1.2 to +3.3 ppm and
from -2.4 to +1.3 ppm, respectively. The
bias of ethanol analysis due to interfering
compounds ranged from -0.8% to +2.2%,
the average absolute bias being 0.8%.
Similarly, the bias of methanol analysis
ranged from -5.6% to +3.2%, the average
absolute bias being 1.7%.
7.2.5. Stability
The concentration of breath components
decreased if the sample was stored in the
measuring cell (Table 9). The relative
decrease in the component was
approximately the same regardless of the
original concentration.
Table 7. Lower limits of quantification for components in five different matrixes.
in N2 in simulated breath spiked with *
Component none ethanol† methanol‡ Marinol§
ppm [µg/l] ppm [µg/l] ppm [µg/l] ppm [µg/l] ppm [µg/l]
Ethanol 4.4 [8.0] 6.5 [11.9] 6.9 [12.7]
Methanol 1.8 [2.2] 5.2 [6.6] 2.4 [3.0] 2.6 [3.3]
1-propanol 4.0 [9.6] 4.3 [10.3] 4.3 [10.2] 7.3 [17.5] 3.4 [8.2]
2-propanol 2.9 [7.0] 4.7 [11.3] 2.5 [6.0] 3.9 [9.3]
Acetone 1.2 [2.8] 2.2 [5.0] 1.3 [2.9] 1.7 [3.8]
Methane 0.8 [0.5] 2.6 [1.7] 0.8 [0.5] 1.8 [1.2] 0.7 [0.4]
Butane 1.1 [2.6] 2.3 [5.2] 2.1 [4.9] 2.6 [5.9] 2.6 [6.1]
MEK 0.7 [2.1] 3.6 [10.3] 3.6 [10.3] 3.1 [8.8]
MIBK 1.3 [5.0] 2.3 [9.1] 1.5 [6.1] 4.1 [16.3]
MTBE 0.4 [1.5] 1.0 [3.4] 0.8 [2.6] 1.6 [5.5] 2.5 [8.7]
Toluene 0.7 [2.5] 1.3 [4.8] 1.2 [4.3] 1.6 [5.8] 1.1 [4.2]
Diethyl ether 0.4 [1.2] 0.6 [1.8] 0.5 [1.3] 0.7 [2.0] 1.3 [3.7]
Ethyl acetate 0.2 [0.7] 0.5 [1.9] 0.3 [0.9] 0.3 [1.0] 0.4 [1.3]
Carbon monoxide 1.2 [1.4] 1.5 [1.7] 1.7 [1.9] 2.8 [3.1] 1.6 [1.8]
* Simulated breath: carbon monoxide 5 vol% and water 2.5 vol% in N2
† Sample ethanol concentration 500 ppm
‡ Sample methanol concentration 500 ppm
§ Sample contains ethanol 440 ppm, 2-propanol 41 ppm, acetone 250 ppm, MEK 53 ppm, MIBK 24 ppm
MEK = methyl ethyl ketone; MIBK = methyl isobutyl ketone; MTBE = methyl tert-butyl ether
Table 9. Sample stability.
Storage time Sample concentrationcompared to original (%)
(min) EtOH CO2 H2O
15 98 98 96
30 96 97 92
60 92 95 87
120 86 91 79
180 81 86 72
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Table 8. The effect of solvents on the breath ethanol and methanol readings.
Interferent Concentration Effect of solvent on analysis resultsof ethanol (150 ppm)
Effect of solvent on analysis results
of methanol (50 ppm)
(ppm) mean(%)
95% confidence
interval for mean
mean
(%)
95% confidence
interval for mean
Ethanol 250 -0.1 -2.1 – 2.0
500 -1.8 -4.6 – 1.0
Methanol 150 0.4 0.1 – 0.7
300 1.0 0.3 – 1.7
1-propanol 150 -0.3 -1.0 – 0.5
300 0.1 -1.0 – 1.1
2-propanol 150 0.4 0.2 – 0.5 -1.8 -3.4 – -0.3
300 0.4 -0.1 – 0.9 -1.1 -2.8 – 0.7
Acetone 150 0.8 0.2 – 1.3
300 0.3 -0.4 – 1.0
400 1.1 0.8 – 1.5 -2.1 -3.1 – -1.0
800 1.5 0.5 – 2.5 -4.0 -5.9 – -2.1
MEK 150 0.6 0.2 – 0.9 0.0 -2.5 – 2.6
300 0.9 0.3 – 1.6 -0.6 -1.3 – 0.1
MIBK 150 0.8 0.4 – 1.2 2.0 0.1 – 3.8
300 1.9 1.6 – 2.2 1.2 -1.0 – 3.4
Diethyl ether 400 -0.7 -0.9 – -0.4 -1.3 -2.8 – 0.3
800 0.0 -0.6 – 0.5 -2.1 -3.1 – -1.1
Ethyl acetate 150 1.4 0.8 – 2.1 -0.6 -2.0 – 0.8
300 0.5 -0.5 – 1.4 -2.9 -3.3 – -2.4
MEK = methyl ethyl ketone; MIBK = methyl isobutyl ketone
Figure 16. Blood-breath ratio of ethanol and methanol (dots) during the treatment of
methanol intoxication (n = 5). The lines represent the individual participants’ ethanol and
methanol blood concentration.
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7.3. Feasibility of the Gasmet FT-
IR analyzer in clinical settings
7.3.1. Correlation of blood and breath
concentrations
During the postabsorptive phase, the
ethanol concentrations measured in the
exhaled breath of volunteers (BrEC, ppm)
correlated linearly with the blood
concentrations (BEC, g/l): BrEC =
203×BEC, r2 = 0.81 (Study I). The results
of the analysis of one person’s samples
seemed to differ from those of the others
noticeably. When the measurements of this
subject were ignored, the equation became
BrEC = 199×BEC, r2 = 0.95. The mean
[SD] calculated blood-breath ratios were
1,616 [276], 2,216 [304] and 2,466 [216]
at the absorption, plateau and postabsorp-
tion phases, respectively.
In the study on methanol intoxica-
tion, the calculated blood-breath ratios
were high and varied inter-individually
during the first hours of treatment (Figure
16). At that time, most of the patients
required extensive support of their vital
functions. They were treated with vaso-
active medication and received large
13%15%RSD: 15% 14%RSD: 17%
MethanolEthanol
Figure 17. Linear regression lines express the correlation between ethanol and
methanol blood and breath concentrations. Relative residuals express the deviation of
breath analysis results from the regression line. The regression line was calculated from
the data after six hours of patient arrival. The relative standard deviation (RSD) of the
analysis results was calculated from all data points. Outline and solid symbols represent,
respectively, the data collected before and six hours after patient arrival.
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amounts of intravenous fluids, among
other therapies. Four patients were initially
connected to a respirator. After the first six
hours of treatment, the measured breath
ethanol (BrEC, ppm) and methanol
(BrMC, ppm) concentrations correlated
fairly well with the respective blood
ethanol (BEC, g/l) and methanol (BMC,
g/l) concentrations: BrEC = 205×BMC, r2
= 0.90, n = 35; BrMC = 257×BMC, r2 =
0.99, n = 35 (Figure 17, page 51).
The relative residuals were high. The
relative standard deviation was 15% for
ethanol and 13%–17% for methanol. The
methanol relative standard deviation was
highest in blood concentrations below 6
mmol/l.
The blood-breath ratios calculated
from the linear regression coefficients
were 2,668 for ethanol and 3,063 for
methanol. When compared to the in vivo
literature values, the ethanol blood-breath
ratio exceeded even the range (Table 2,
page 20). It was 16% higher than the
literature median. The methanol blood-
breath ratio had not been determined
before. The in vitro blood-air partition
coefficients have been determined mainly
at 37 ºC. According to Jones, the
coefficient for methanol is 19% higher in
34 ºC than in 37 ºC (Jones et al. 1990).
The methanol blood-breath ratio was 3%
smaller than the median (3,092) of the
temperature-corrected water-air partition
coefficients in the literature.
7.3.2. Sampling and analyzing
The delivery or collection of the samples
was successful in five out of six methanol
intoxication cases (four comatose, one
cooperative). The failed case was a non-
cooperative man. He had not been
intubated, and the samples had to be taken
by means of a face mask. The sampling
was laborious and the CO2 concentration
remained low, thus rendering the samples
unsuitable for quantitative analysis.
In the emergency room population,
the sampling and analysis was successful
in 589 out of 609 cases (96.7%). Samples
were considered failed in 16 cases because
of low exhaled carbon dioxide (< 3 vol%,
median exhaled CO2 2.7 vol%). Nurses
considered the sampling difficult in only
two of these cases. Technical problems in
computing caused the loss of data on four
additional participants. Difficulties in
sampling appeared in some cases due to a
lack of patient cooperation (15 confused
and 4 comatose patients). An acceptable
sample was finally obtained from all but
two of these patients.
The exhaled CO2 concentration
varied quite a lot between the subsequent
samples of the individuals among the men
intoxicated with technical ethanol
products. This was mainly due to the
reduced coordination of the participants.
Nevertheless, even very inebriated men
were able to give an acceptable sample in
a few attempts.
7.4. Response of the Dräger
7110 evidential breath analyzer
to intoxicating solvents
Most of the possible interfering
compounds studied either caused the
“interference detected” message in very
low concentrations (methanol, ethyl
acetate and diethyl ether) or had a
negligible effect on ethanol analysis (small
coefficient (Cx); acetone, methyl ethyl
ketone and methyl isobutyl ketone). When
combined with ethanol, even possibly
toxic concentrations of acetone and
propanols did not activate the
“interference detected” message.
Additionally, 1-propanol and 2-propanol
had a significant impact on ethanol
readings. 1-propanol had a more
pronounced effect in comparison with 2-
propanol, the coefficients being 0.60 and
0.26, respectively. The effects of
potentially interfering compounds on the
Dräger 7110 evidential breath analyzer’s
ethanol recordings are summarized in
Table 10.
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Table 10. The effect of interferents on the Dräger 7110 evidential breath analyzer readings.
The values in bold correspond with potentially toxic blood concentrations.
EtOH conc. Interferent Coefficient * Max. interf. conc. † Reading ‡ Error §
mg/l (Cx) mg/l [ppm] mg/l (%)
0 1-Propanol 0.58 0.17 [70] 0.09
0.24 Methanol 1.35 0.019 [15] 0.26 +8
Acetone 0.017 1.8 [800] ¶ 0.27 +13
Ethyl acetate 0.54 0.052 [15] 0.27 +13
Diethyl ether (( 0.044 [15] 0.25 +4
MEK 0.025 0.86 [300] ¶ 0.26 +8
MIBK 0.018 1.2 [300] ¶ 0.26 +8
2-Propanol 0.26 0.17 [70] 0.28 +17
1-Propanol 0.60 0.48 [200] 0.52 +117
0.60 Ethyl acetate 0.65 0.10 [30] 0.67 +12
2-Propanol 0.25 0.60 [250] 0.74 +23
1-Propanol 0.59 1.4 [600] ¶ 1.40 +133
* Biasing power of an interferent on the ethanol reading (see text for details)
† Highest observed concentration of a possible interfering compound not to trigger the “interfering compound” sign
‡ Analysis result at the maximum interference level
§ Relative difference between the true ethanol concentration and the reading
¶ Higher concentrations were not tested
(( Regression not relevant due to a small number of observations
MEK = methyl ethyl ketone; MIBK = methyl isobutyl ketone
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8. Discussion
8.1. Configuration of the Gasmet
FT-IR analyzer for breath testing
8.1.1. Impact of sampling system
components on analysis results
According to our studies, 0.5 l of the
sample gas was required to achieve 95%
sample concentration into the 200 ml gas
cell. The gas mixing was tested with 0.5–
1.0 l/min flow. Nevertheless, even the 1.0
l/min flow is over tenfold lower than the
flow in a normal exhalation. The higher
gas flow was not tested, because the
mixing would have occurred during a short
time, allowing only few FT-IR
measurements to be made.
According to the actual sampling
experiment, a 1.5 l exhalation was needed
to achieve 70% of the final CO2
concentration. In contrast to the literature
(Hlastala 1998), no plateau for CO2 was
ever reached. 1.5 l is the point where the
CO2 concentration curve bends to a more
horizontal direction. From this point on,
the changes in the exhaled volume would
lead to a smaller difference in the CO2
concentration. Hence, it was rational to
require over 3 vol% CO2 in an exhaled
sample for FT-IR measuremets. The low
end-exhaled CO2 and the missing of an
“alveolar plateau” might have been, at
least partially, due to the sampling
protocol. Deep inhalation immediately
before the exhalation might have caused
dilution of the CO2 in the lungs, especially
in the case of a test subject with a large
lung volume. Further investigation is
required to verify this assumption.
The total dead space due to the
bacterial filter (35 ml) and hosing (25 ml)
was 60 ml. The volume of the analyzer’s
hosing and measuring cell should be
smaller in order to reduce the required
sample volume. In the beginning of the
study, the measuring cell size was
minimized to be able to catch an alveolar
sample at the end of the exhalation. Still,
the cell makes up 70% of the volume of
the sampling system. However, if the cell
volume were reduced even further, the
analyzer’s performance would be
impaired. A shorter sample line would be
impractical, and smaller sample line
diameter would lead to higher delivery
pressure. The bacterial filter could be
replaced with a smaller one, perhaps
without significantly reducing the
protection.
A very low resistance to blow has a
few advantages. The effort required to
give a sample is minimal, and even fragile
elderly individuals or very inebriated
persons are thus able to produce a
satisfactory sample. Furthermore, the
ventilation of a comatose patient is
possible through the low-resistance
measuring cell. A high delivery pressure
has been supposed to prevent the attaining
of an exhalation plateau and low pressures
to generate a non-uniform exhalation
profile (Gullberg 1990). In our studies, a
higher resistance seemed to lead to a
higher expired volume and higher end tidal
CO2. The measured ethanol concentration
was independent of the delivery pressure.
The effect of condensation was
significant, especially in the water
analysis. Only a small part of the effect
might have been due to the dead space
effect, because the test subject was a 192
cm, 90 kg man with a large lung volume.
The dead space effect would be more
significant with a smaller sample volume.
The effect of condensation on low-
concentration ethanol was clearly smaller
than on saturated water vapour. In any
case, the problem could be easily solved
by developing a heated filter and sampling
hose.
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8.1.2. Analysis software configuration in
relation to breath composition
The objective was to configure analysis
settings so as to minimize the effect of
interfering components and maximize the
analytical accuracy. Due to a considerable
number of components in the reference
library, negative component concentra-
tions were mostly inhibited by the
software settings. This is acceptable,
because the background sample should be
free of the library components (Saarinen et
al. 1991).
Negative analysis results had to be
allowed for methane in the screening study
with ER attendees (Study III), because
medical oxygen gas was used for zero
calibration. Unexpectedly, the medical
oxygen contained five to ten ppm of
methane, which made it impossible to
express the absolute exhaled methane
concentration. Because the ambient air
was measured before each patient, it was
possible to calculate and show the exhaled
methane concentration over the ambient
air value. This points out the importance of
analyzing the ambient air before breath
testing.
Despite the ability of the analyzer to
detect even subtoxic levels of common
solvents other than ethylene glycol, the
screening of ER-attendees’ exhaled breath
revealed only one case of methyl ethyl
ketone, in addition to ethanol and acetone.
A considerable exhaled concentration of
ethanol was a common finding, especially
among male trauma patients at night.
Elevated acetone in ten patients was
related to an apparently strong alcohol
dependence or undernourishment.
Most of the men tested in Study V
had drunk technical ethanol products and
had a variety of solvents in their breath.
The breath ethanol concentrations
measured were quite high. These
concentrations correspond to blood
concentrations of 1.3 to 2.7 g/l, if a blood-
breath equilibration ratio of 1,616 is used
for calculations in the absorption phase.
The most commonly misused product was
Marinol (cooker fuel). In addition to
ethanol (over 80% w/w), it contains MEK
(2% w/w), MIBK (2% w/w) and 2-
propanol (1%–5% w/w) (Berner 2005). All
of these components were expectedly
detected in the exhaled breath of
alcoholics.
Ketoacidosis and high acetone
concentrations have been found in
alcoholics with unknown causes of death
(Brinkmann et al. 1998). In addition to
ketoacidosis, intoxication with 2-propanol
or the use of technical ethanol products
containing 2-propanol leads to very high
blood acetone levels (Kelner et al. 1983).
In Study V, breath screening revealed
unexpectedly high concentrations of
acetone. The high acetone concentrations
measured in our study were most probably
due to metabolism of 2-propanol.
8.2. Performance of the Gasmet
FT-IR analyzer in solvent breath
testing
8.2.1. Calibration model (linearity)
The linearity was checked by analyzing
samples generated with the Temet
calibrator. The variation due to the
calibrator was estimated to be less than ±
2.5%. In spite of that, one of the analyzed
ethanol samples was statistically an
outlier. Because only one reference sample
was prepared and analyzed at each
concentration level, random error could
not be excluded. Moreover, no other
analysis method was used to confirm the
sample concentration.
According to the validation protocol
(Peters et al. 2002), the outlier should be
excluded. This was not done in the original
publication. When the outlier was later
excluded, the measured ethanol
absorbance of the remaining samples
correlated linearly with the calculated
concentration. The intercept of the
regression equation was also very small;
the calibration line went almost through
the origo. The relative residual of the
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outlier was -6.5%; not very high but more
than would have been anticipated.
Methanol absorbance behaved
somewhat non-linearly. This may be
partially due to the fact that at high
concentrations, the growth of the peak in
the IR-spectrum decelerates. The sharp
shape of the methanol peak at 1,057 cm-1
augments this phenomenon. When the two
points over 0.4 absorbance units were
deleted, the remaining six points remained
significantly closer to the straight line
passing the origo very closely.
The non-linear behaviour of
absorbance as a function of concentration,
if not corrected, can produce significant
quantitative errors, because the analysis
algorithm assumes a linear relationship
between absorbance and concentration.
The extent of the non-linearity will vary
depending on the natural line width of the
absorption band and the resolution of the
spectrometer. The correction can be
accomplished by determining the non-
linearity factor from the reference spectra
at different concentrations (Bak et al.
1995). The effect of non-linearity can also
be minimized by measuring a sufficient
amount of reference spectra within the
non-linear concentration range.
The curving could have been mostly
avoided by calculating the linearity from a
blunter type peak, for example, at 2,972
cm-1 for ethanol and 2,979 cm-1 for
methanol. On the other hand, the non-
linearity can be an advantage in increasing
the dynamic range of quantitative analysis.
It is possible to measure high concentra-
tions with a low-resolution instrument,
because at low resolution, the absorbances
measured at high concentrations are lower
than at high resolution. This is a
significant advantage in the case of a low
concentration component required to be
measured in the presence of strongly
absorbing components with a high degree
of spectral overlap (Saarinen et al. 1991).
8.2.2. Accuracy
As we did not have any secondary analysis
method, we had to compare the results of
the bubbling test analyses with previously
published values. According to a
comprehensive review, the literature
values for Henry’s law constants vary
widely (Sander 1999). The reference
values used in this study originate from
publications of experimental determina-
tions of Henry’s law constants. The values
calculated based on our study results were
slightly lower than those found in the
literature. This was clearly shown in the
bias calculations.
The tests with the calibrator system
proved a very good accuracy of the
analyzer, except for the bias in the
methanol measurements.
8.2.3. Sensitivity
The Gasmet FT-IR analyzer was
adequately sensitive in ethanol and
methanol breath analysis, even in the
presence of high concentrations of other
solvents. The calculated LLOQ for
methanol was one tenth of the toxic
concentration. The analyzer was most
sensitive when a single component was
analyzed in plain N2. Even though the
overlapping compounds were taken into
account in the analysis method, the strong
absorptions of the matrix components in
the simulated human breath increased the
LLOQ. When ethanol, methanol or even
more components were added to the
matrix, the LLOQ did not increase further.
8.2.4. Selectivity
Dadgar and co-workers (1995) proposed to
determine the selectivity by analyzing up
to 20 blank samples spiked with an analyte
at the lower limit of quantification and, if
possible, with interferents at their highest
likely concentrations. In our studies, high
concentrations of interferents were used,
but the analyte concentration was not at
LLOQ level. Instead, the selectivity
measurements were made at clinically
critical levels.
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The Gasmet FT-IR analyzer is
designed to analyze several components
simultaneously. Due to this feature, it was
also able to cope with several possible
interfering compounds. All of the
interfering effects remained well below
acceptable limits.
8.2.5. Stability
The decrease in the sample components
during storage was more probably due to
leakage through the sampling hose than
any chemical reaction inside the
measuring cell. New components were not
detected during the storage test. The
significant decrease during the three-hour
storage test is practically inconsequential,
because the sample is blown directly into
the sampling cell and usually analyzed
immediately thereafter. A few minutes’
delay in analysis would cause practically
no error in results.
8.2.6. Procedural aspects
Preparing an exact gaseous sample is a
challenge, especially in low analyte
concentrations. The bubbling method was
used in the early study period. It is easy to
set up and use, but it has some
disadvantages. The vaporization depends
strongly on temperature. According to
their thermodynamic properties, the
components in the solution vaporize at
varying rates. The composition of the
sample gradually changes, if the sample
gas is not led back to the bubbling system
and the temperature controlled strictly.
Interactions between the components in
the liquid phase are also possible, although
unlikely in dilute solutions.
Due to these factors, a breath
simulator based on Temet calibrators was
developed. The main advantage of this
system was the possibility to easily
calculate and adjust the composition of the
sample gas, simply by regulating the speed
of the syringe pumps. The main problem
was a sway in the injection speed of the
syringe pumps. The sway was clearly
detected by the analyzer, because of the
small measuring cell volume. Obviously,
the sway was most disturbing at low
syringe injection speeds. The problem was
solved by adding a heated 1.0 l reservoir to
the system.
The sample stabilization after
changes was always verified by non-stop 5
s measurements. Even though, in theory,
the calibrator system accurately vaporized
the components into the stream of the
carrier gas, the sample was sometimes
unacceptable. The problems mostly
occurred with methanol. Typically, the
stabile state was not achieved or it was
significantly delayed. The problem was
usually solved by resetting the methanol
syringe once or twice. In spite of this, the
measured methanol concentration
remained, for the most part, lower than
could have been theoretically anticipated.
Even though no explanation was found for
the malfunction of the calibrator system, it
probably explains part of the methanol
bias.
The performance testing in a
laboratory was carried out without a
secondary analysis method. The nominal
concentration in the bubbling tests was
estimated according to the literature values
for Henry’s law constants, the range of
which was quite wide. The nominal values
for the calibrator system were calculated
on the basis of the carrier gas flow and
injection rates. If results of a secondary
analysis method had been available, the
error component due to the calibrator
system could have been estimated. Even
though the FT-IR method is traceable to
the principal laws of physical chemistry,
further investigation is needed in order to
exactly validate the breath test method—
e.g., by comparing it with another analysis
method.
8.3. Feasibility of the Gasmet FT-
IR analyzer in clinical settings
The most challenging part of solvent
breath testing is estimating the correspond-
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ing blood concentration. The criteria for
precision and bias for a bioanalytical
method were summarized in a recent
review (Peters et al. 2002). The precision
should stay within 15% relative standard
deviation, with the exception of the lower
limit of quantification (LLOQ) where 20%
relative standard deviation is accepted.
Bias was required to be within ±15% of
the accepted true value, with the exception
of the LLOQ where ±20% is accepted. If
blood concentration is to be determined
with a breath test, the human body
becomes, so to speak, a part of the
bioanalytical method. The abnormal vital
functions of a seriously ill patient add
many factors of uncertainty to the method.
Fortunately, on many clinical
occasions—such as diagnosing a solvent
intoxication—an exact quantification is
not necessary. It is enough to know the
name of the intoxicant and an
approximated concentration. In the
following, the feasibility of the Gasmet
FT-IR analyzer is discussed from the
clinical point of view.
8.3.1. Correlation of blood and breath
concentrations
The blood-breath ratios from the
experiments with volunteers agreed with
previous investigations and showed higher
and more constant values in the
postabsorptive phase. The number of
observations in this preliminary study was
very limited.
It is important from the clinical
perspective that the lower limit of
quantification is low enough to enable any
toxic amount of solvent to be found.
Methanol is considered toxic in blood
concentrations over 6 mmol/l. Even
though the linear regression parameters of
blood-breath pairs derived from methanol
intoxications showed a quite good linear
fit, the variation in the standardized
residuals remained extensive even after
omitting the data from the first six hours.
The high and widely variable ethanol and
methanol blood-breath ratios in the
methanol-intoxicated patients during the
first hours of treatment could be explained
by an unstable cardiorespiratory state and
a marked ventilation-perfusion mismatch
in the lungs.
Due to a limited number of blood
and breath measurement pairs, the
calculation of relative standard deviation
for in vivo data was not statistically
convincing. Nevertheless, these figures
support the observational impression that
the method was only just accurate enough
to detect the mildest methanol
intoxication.
Collecting the breath sampling was
difficult with one of the methanol-
intoxicated patients. The CO2
concentration in a typical breath sample of
this patient was 2.3 vol%. At the same
time, the arterial pCO2 was 5.0 kPa and the
methanol blood concentration 12.1
mmol/l. In spite of the low-quality breath
sample, the measured exhaled methanol
concentration was 68 ppm. This case
affirms the above assumption of methanol
detection in subtoxic levels.
As was pointed out previously, there
is no single true value for a blood-breath
ratio of a solvent. In fact, only the blood-
breath ratio for ethanol has been
reasonably estimated. The methanol
blood-breath ratio in toxic concentrations
was determined for the first time in Study
II. This blood-breath ratio was compared
to in vitro blood-air partition coefficients
in the literature. The in vitro coefficients
do not account for the complex excretion
of the solvents in the human respiratory
system. The difference (bias) to the
literature values was surprisingly small, if
one considers the critical illness of the
intoxicated patients. As we did not have
any secondary analysis method for breath
samples, the observed difference may
derive from factors related both to the
analyzer and the patients. During the
treatment, the bias could be individually
compensated for by comparing the breath
analysis results with values derived from
blood tests.
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To discover the possible interfering
compounds, hundreds of breath samples
were screened in Studies III and V. The
effect of these interfering compounds on
the results of ethanol and methanol
analysis was determined by laboratory
tests with simulated breath samples, as
described above. Because the composition
of the simulated breath is very close to
genuine human breath, the results of the in
vitro interference studies are most
probably valid in vivo, as well.
8.3.2. Sampling and analyzing
The Gasmet FT-IR analyzer was easy to
use, even for non-laboratory personnel. As
a battery-operated device, it was easy to
carry to the bedside in the emergency
room study. Even fragile elderly patients
were able to give a satisfactory breath
sample. Quickly trained nurses succeeded
in obtaining samples, even from
unconscious patients. Adding a no-return
valve into the sampling hose would be a
simple improvement to assist patients in
correctly blowing into the analyzer. It
would also facilitate the timing of the
manual valve closure.
The nearly on-line breath solvent
measurement turned out to be a valuable
aid in controlling the haemodialysis and
ethanol treatments (Figure 18). For
example, it was clearly seen from the
breath test trends how slowly methanol
would have been eliminated without the
third haemodialysis.
8.3.3. Procedural aspects
The method of sampling exhaled breath
varies between individual studies in the
literature. One common method is to
inhale deeply and hold the breath for 15 to
25 seconds prior to exhaling. The purpose
is to get a more “alveolar” sample, as the
volatile compounds have time to
equilibrate between the blood and breath.
The non-breath-holding method was
chosen for this study to get appropriate
Figure 18. Elimination of methanol during treatment of intoxication. Three six-hour haemo-
dialysis treatments (HD) were performed. Between the second and third HD, the exhaled
methanol concentration declined only from 90 to 70 ppm. An exhaled ethanol concentration
of 200 ppm corresponds with the target blood concentration of 1 g/l.
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and equivalent samples even from non-
cooperative patients. This choice was
supported by Kirkham and co-workers
(1988). They achieved an equally good
correlation without breath-holding, even
for gases changing predominantly in the
alveoli, such as carbon monoxide.
Two subsequent breath samples were
averaged to decrease random variation. An
adequately high and roughly similar
carbon dioxide level was required for the
two samples. This method was used in all
studies, except in Study V. Due to poor
cooperation, the blowing technique of the
inebriated men varied to a great extent
between subsequent samples. In these
circumstances, one good sample was
considered adequate.
The large measuring cell size (0.2 l)
is a clear disadvantage of the FT-IR
method. The gas mixing in the measuring
cell requires 0.4–0.7 l of extra sample
volume, and dilutes the end-expiratory
sample in all cases. Even though the
sample was diluted and not truly alveolar,
the solvent blood-breath correlation stayed
linear and the variation in analysis result
was acceptable for rough clinical purposes.
8.4. Value of the Dräger 7110
evidential breath analyzer in
revealing the presence of
intoxicating solvents
The Dräger 7110 evidential breath
analyzer has been designed to analyze
breath ethanol accurately, in spite of the
other breath components. In order to be
detected, a possible interfering compound
must have a sufficient vapour pressure to
pass from the blood to the breath, and the
resulting breath concentration must be
high enough to cause a significant
difference between the responses of the
EC and IR detectors (Lagois 2000).
Neither the electro-chemical detector nor
the IR-method is absolutely specific to
ethanol.
A detection of volatile compounds
other than ethanol might in some rare
cases reveal poisoning. With regard to
methanol, this could be of vital
importance. The Dräger 7110 evidential
breath analyzer was tested in order to
determine whether it could be utilized in
diagnosing a solvent intoxication.
The Dräger 7110 evidential breath
analyzer was able to detect most of the
potentially interfering common solvents in
concentration levels which did not
significantly affect ethanol analysis.
Methanol had a very strong relative effect
on the ethanol reading (coefficient 1.35),
but the interference was detected in a very
low concentration, before it began to
influence the results of the ethanol
analysis. The threshold concentration in
breath was 15 ppm [19 µg/l]. It
corresponds with a sub-toxic blood
concentration (< 2 mmol/l).
On the other hand, acetone and
propanols were not detected even in toxic
concentrations, when combined with
ethanol. Co-existence of 1- or 2-propanol
significantly interfered with the ethanol
analysis without activating the “interfering
compound” message. The effect of 1-
propanol on ethanol readings was more
than two times stronger than that of 2-
propanol. Corresponding interference by
2-propanol has been published earlier
(Lagois 2000).
According to our results, it seems
that a successful breath ethanol analysis by
the Dräger 7110 evidential breath analyzer
could exclude any significant methanol
intoxication. In contrast to the Gasmet FT-
IR analyzer, the Dräger 7110 evidential
breath analyzer is not intended or equipped
to qualify the interfering component.
Therefore, verifying a suspected
intoxication by methanol (or other volatile
compound) relies on clinical signs and
symptoms, if the “interfering compound”
message is displayed. In hospital settings,
the reason for the “interfering compound”
message would naturally lead to further
examinations (blood tests).
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8.5. Ethylene glycol
Most of the solvent analyses are required
in order to exclude a toxic solvent
intoxication. Ethylene glycol is an
important intoxicating solvent in addition
to methanol and 2-propanol. Unfortu-
nately, a toxic blood concentration of 8–24
mmol/l at 34 ºC would possibly lead to
approximately 5–16 ppb in air; this is at
least a hundred times below the assumable
detection limit of the Gasmet FT-IR
analyzer (Equation 10.3, estimated
temperature correction term 104 K). For
the same reason, an ethylene glycol
intoxication will not activate the
“interfering compound” message in the
Dräger 7110 evidential breath analyzer. In
other words, these analyzers can not be
used for ethylene glycol intoxication
diagnostics, which leads to a marked
weakness in the breath diagnostics of a
typical case of severe metabolic acidosis.
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9. Conclusions
The following conclusions can be drawn on the basis of the present studies:
1. The Gasmet FT-IR analyzer proved suitable for breath testing after the sample cell fittings
were widened and the cell size reduced. The analyzer was also equipped with a battery for
bedside diagnostics. In the future, a heated sampling hose and filter as well as a non-return
valve are required for the sampling system.
The analysis method was insensitive to the hundreds of minor endogenous or exogenous
breath components reported in the literature. The most abundant detectable breath
components in the breath were carbon dioxide, water, methane, carbon monoxide and
acetone. Measurable amounts of solvents were also detected in breath samples after
ingestion of technical ethanol products. All of the measurable components were included
in the reference library and were thus taken into account in the analysis procedure. The
settings of the analysis software were adjusted for breath testing.
(Studies I–III, V)
2. The Gasmet FT-IR analyzer proved suitable for solvent intoxication breath testing where
linearity, accuracy, selectivity and sensitivity were concerned. In laboratory settings, the
lower limit of detection for methanol was 10 times lower than the lowest toxic
concentration, even in the presence of a high concentration of other solvents. Toxic blood
concentrations of ethylene glycol could not be detected by this method.
(Studies I, V)
3. The analyzer was easy to use and also suitable for use in non-laboratory settings by non-
laboratory personnel. Even though the blood-breath ratio of methanol varied to a great
extent in clinical settings, the method was just accurate enough to detect the mildest
methanol intoxication.
(Studies I–III, V)
4. It seemed that a successful breath ethanol analysis by the Dräger 7110 evidential breath
analyzer could exclude any significant methanol intoxication. In contrast, very high levels
of acetone, 1-propanol, and 2-propanol were not detected in simulated breath. Due to its
physiochemical properties, ethylene glycol will not be detected either. The Dräger 7110
evidential breath ethanol analyzer is not intended for and equipped to recognize the
interfering component. In case an interfering compound is detected, the suspicion of
intoxication by a toxic solvent relies on clinical signs and symptoms.
(Study IV)
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10. Equations
10.1. Blood-breath ratio
Correlation between blood and breath concentrations is determined by the equation:
Blood
Breath
C
BBR
C

where BBR = blood-breath ratio; CBlood = concentration of solvent in the blood;
CBreath = concentration of solvent in the breath.
10.2. Liquid-air partition coefficient
Blood-air or water-air partition coefficients were calculated by the following equation:
l l l
la
ga g
c c c RT
pc p
RT
   
where la = liquid-air partition coefficient; cl = concentration in liquid phase [mol/l];
ca = concentration in gas phase [mol/l]; R = gas constant [0.08206 atm l / mol K];
T = temperature [K]; pg = partial pressure in gas phase [atm].
10.3. Henry’s law
Henry's law predicts a linear relationship between the partial vapour pressure of the solute
and its concentration in the liquid phase (Sander 1999):
l
H
g
c
k
p

where kH = Henry’s law constant for the component; cl = concentration of the component in
the liquid phase [mol/l]; pg = partial pressure of the component in the gas phase [atm]. The
Henry’s law is valid for ideal dilute solutions—i.e., the mole fraction of the solute should be
below 0.01. Examples of the constants are shown in Table 3 (page 21).
The Henry’s law constant depends strongly on temperature and slightly on pressure. In
constant pressure, the effect of temperature change on the constant value can be calculated:
1 1exp solnH H
Hk k
R T T


   
    
  
where kH = Henry’s law constant [M/atm] for the component in the new temperature T [K];

Hk = Henry’s law constant [M/atm] for the component at the standard temperature
T
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[298.15 K]; ΔsolnH = enthalpy of the solution [L atm mol-1]; R = gas constant [8.2057 * 10-2 l
atm mol-1 K-1].
The calculation of the temperature effect is possible, because empirical determinations of the
term lnso
H
R

have been published in the literature (Sander 1999).
10.4. Ventilation-perfusion ratio
The fraction of the compound excreted (E) to the breath is dependent on alveolar blood flow
and pulmonary ventilation according to the equation:




QV
QVE

where λ = blood-gas partition ratio;

V = alveolar ventilation;

Q = alveolar blood flow
(Hlastala et al. 1988). In a normal subject at rest total

V is approximately 4.5 l/min and the
corresponding total Q 5.0 l/min. Overall ventilation-perfusion ratio (

QV ) equals 0.9 (range
0.7 to 1.0). In different regions of the lung  QV varies widely, from 0.5 to 3.0.
10.5. Beer’s law
According to Beer’s law, the absorbance of the IR-radiation is directly proportional to the
concentration of the sample (and the path length):
A(v) = -logT(v) = -log[I(v) / I0(v)] = ε(v)cl
where A(ν) = absorbance; T(ν) = transmittance; I0(ν) = the original intensity of the radiation;
I(ν) = the intensity of the radiation passed through the sample; c = concentration of the
sample; l = optical path length (the distance the radiation goes through the sample);
ε(ν) = molar coefficient of absorption of the sample; ν = wave number.
The IR spectrum of the sample is the sum of the spectra of the N components:
1
( ) ( )
N
i
i
A v v cl

 
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10.6. Transmittance and absorbance
A transmittance spectrum is obtained as follows:
0
( )( )
( )
I vT v
I v

where T(v) is transmittance; I(v) is the intensity measured with a sample in the beam (from
the sample single beam spectrum); I0(v) is the intensity measured from the background
spectrum.
The absorbance spectrum can be calculated from the transmittance spectrum using the
following equation:
( ) log ( )A v T v 
where A(v) is the absorbance.
10.7. Resolution
The resolution ( v ) of an FT-IR instrument depends on the maximum displacement (δmax)
of the moving mirror according to the following equation:
max
1v

 
10.8. Precision
The precision was calculated by one-way ANOVA and the following equations (Bookbinder
et al. 1986):
Within-day variance: 2WD WGSD MS
Between-day variance: 2 BG WGBD
MS MSSD
n


Total variance: 2 2 2( )I CT BD WDSD SD SD 
where MSWG = within-groups mean squares value from the ANOVA results;
MSBG = between-groups mean squares value from the ANOVA results; n = number of
measurements per day.
Coefficient of variance:
2
100XX
SD
CV [%]
x
 
where 2XXSD = within-day, between-day or total variance.
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10.9. Bias
The bias of analysis results was calculated for ethanol and methanol with the equation:
x µBias [%]
µ


where x = mean of the measured values; μ = nominal value.
10.10. Limits of detection and quantification
The limits of detection (LOD) and the lower limits of quantification (LLOQ) were calculated
with the equations:
LOD = |C0| + 3 * SD
LLOQ = |C0| + 10 * SD
where |C0| = absolute value of the measured component concentration; SD = standard
deviation of analysis results of the component in question.
10.11. Average absolute bias
1
n
j
j
Bias [%]
Average absolute bias [%]
n



where j = number of different combinations of interfering compounds and their
concentrations.
10.12. Coefficient for biasing power
The coefficient Cx describes the biasing power of the interfering compounds on the ethanol
readings:
EtOHapp = Cx × Interfx + EtOHact
where EtOHapp = apparent ethanol concentration displayed by the Dräger 7110 evidential
breath analyzer; Interfx = concentration of the interfering component X in the sample;
EtOHact = actual ethanol concentration of the sample.
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